Genetic pathways of aging and their relevance in the dog as a natural model of human aging by Sándor, Sára & Kubinyi, Enikő
  
 
Genetic pathways of aging and their
relevance in the dog as a natural model
of human aging
 Sára Sándor1*, Eniko Kubinyi1
 
1Department of Ethology, Institute of Biology, Eötvös Loránd University, Hungary
 Submitted to Journal:
 Frontiers in Genetics
 Specialty Section:
 Genetics of Aging
 Article type:
 Review Article
 Manuscript ID:
 464268
 Received on:
 04 Apr 2019
 Revised on:
 13 Aug 2019
 Frontiers website link:
 www.frontiersin.org
In evi
ew
  
 Conflict of interest statement
 The authors declare that the research was conducted in the absence of any commercial or financial
relationships that could be construed as a potential conflict of interest
  
 Author contribution statement
 
S. Sándor collected literature and wrote manuscript parts regarding genetic pathways in aging and in dogs.
E. Kubinyi collected literature and wrote manuscript parts regarding dogs as models in general, environmental and cognitive
factors.
Both authors worked on reviewing the final text.
  
 Keywords
 
Hallmarks of aging, animal aging models, family dogs, aging genetics, dementia research
  
 Abstract
Word count: 228
 
Aging research has experienced a burst scientific efforts in the last decades as the growing ratio of elderly people has begun to
pose an increased burden on the healthcare and pension systems of developed countries. Although many breakthroughs have been
reported in understanding the cellular mechanisms of aging, the intrinsic and extrinsic factors that contribute to senescence on
higher biological levels are still barely understood. The dog, Canis familiaris, has already served as a valuable model of human
physiology and disease. The possible role the dog could play in aging research is still an open question, although utilization of dogs
may hold great promises as they naturally develop age-related cognitive decline, with behavioral and histological characteristics
very similar to that of humans. In this regard, family dogs may possess unmatched potentials as models for investigations on the
complex interactions between environmental, behavioral and genetic factors that determine the course of aging. In this review
we summarize the known genetic pathways in aging and their relevance in dogs, putting emphasis on the yet barely described
nature of certain aging pathways in canines. Reasons for highlighting the dog as a future aging and gerontology model are also
discussed, ranging from its unique evolutionary path shared with humans, its social skills and the fact that family dogs live
together with their owners, and are being exposed to the same environmental effects.
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including the relevance of age related genetic pathways in the species. To the best of our knowledge, currently there is no review
article that aims to cover this specific topic by providing a comprehensive list of already described genetic pathways of ageing and
discussing their research in dogs. We hope that our manuscript could complement current literature on canine ageing by
summarizing all relevant ageing pathways.
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 65 
Introduction 66 
 67 
Dogs (Canis familiaris) are special in the animal kingdom in many aspects. Being the oldest 68 
domesticated species, they accompany humans for approximately 15.000 - 100.000 years, (estimates 69 
depend on the different approaches used to study their origin, see Larson et al., 2012; Thalmann et al., 70 
2013; Vila, 1997). Consequently, they have adapted to the special social environment of human 71 
communities in a way unmatched by any other species and thus earned their rightful title as man’s 72 
best friend. They have also gained diverse functionality throughout the millennia, which resulted in a 73 
phenotypic variability unrivalled by any other species. Recently, the species has also been promoted 74 
to be a model of human physiology and disease. The sequencing of the dog genome (Lindblad-Toh et 75 
al., 2005) and the development of high resolution genotyping arrays to support genome wide 76 
association (GWAS) studies (Hayward et al., 2016) were important steps to open up new perspectives 77 
of genetic investigations in dogs. Recently, a growing number of full genome sequences from various 78 
dog breeds has also been added to the genetic toolkit of canine researchers (Dreger et al., 2016b, 79 
2016a; Kim et al., 2018). The importance of these improvements is clearly visible through the 80 
expanding list of reported disease associated polymorphisms in dogs. Examples, like the famous case 81 
of the narcolepsy causing mutation in the canine Hypocretin Receptor 2 gene (Lin et al., 1999), which 82 
turned the focus of researchers to its human homolog’s role in narcolepsy, have demonstrated how 83 
canine genetics can benefit humans.  84 
Genetic analyses have also helped to shed light on the origin and evolution of dogs and on the 85 
divergence of breeds (Axelsson et al., 2013; Frantz et al., 2016; Freedman et al., 2016; vonHoldt et 86 
al., 2010; Wang et al., 2016) and have revealed numerous genetic variants responsible for their 87 
phenotypic variability. For example, several genes have been shown to affect the body size variability 88 
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of dogs (Hoopes et al., 2012; Plassais et al., 2017; Rimbault et al., 2013; Sutter et al., 2007), which is 89 
unmatched by any other mammalian species. Importantly, dogs also show marked differences in their 90 
expected lifespan in connection with body mass. On average, giant sized breeds (above 50 kg) have 91 
an expected lifespan of 6-8 years, while small sized breeds (below 10 kg) can live up to 14-16 years 92 
(Jimenez, 2016).  93 
This wide range of expected lifespans, together with other aspects, have made dogs promising as 94 
model organisms for aging research (Creevy et al., 2016; Gilmore and Greer, 2015; Hoffman et al., 95 
2018; Kaeberlein et al., 2016; Mazzatenta et al., 2017). In this regard, family dogs living as animal 96 
companions with their owners could be even more relevant than laboratory dogs (Kaeberlein, 2016). 97 
Although laboratory dogs had been traditionally used for a wide range of investigations, including 98 
aging research (Cotman and Head, 2008) they have some major limitations. For example, they 99 
experience a less complex nutritional and environmental history during their life course than family 100 
dogs do, which could lead to major deviances in their base level behavioral parameters. Also, they 101 
usually represent only a few breeds. These aspects clearly reduce the power of laboratory dogs to 102 
correspond with highly variable natural populations, especially when we consider the range of 103 
different aging phenotypes. Actually, describing and characterizing human aging phenotypes is a 104 
main goal of researchers, as such variability leads to fundamental differences in individual courses of 105 
aging. Living a long life with poor health can negatively affect the welfare of both the elderly and 106 
their surroundings. Age-related dementia can especially make a major impact in this regard, rendering 107 
patients unable to live an independent life. Therefore, lifespan and healthspan are considered partly 108 
independent attributes of human aging, leading to the distinction between healthy aging and 109 
pathological aging. Furthermore, in respect to cognitive decline, which can hinder welfare even if no 110 
other diseases are present, some authors suggested to discriminate successful aging as a subtype of 111 
healthy aging, which is characterized by maintained ability to live an autonomous life until death 112 
(Rowe and Kahn, 1987, 2015). In this regard, family dogs clearly surpass laboratory dogs as models, 113 
because they are more abundant, more variable, and are much more likely to reach an old age and to 114 
encounter various aging courses. Although the detailed phenotypic categorization of aging in dogs 115 
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will require further efforts, definitions for frailty, for example, have already been proposed in the 116 
species (Hua et al., 2016).  117 
Nevertheless, it still remains a question, how exactly dogs, especially family dogs can fit in the puzzle 118 
of aging genetics among many already well-established experimental models. Despite the huge 119 
progress in understanding the genetic basis of morphological variability of dogs, still very little is 120 
known about the functional relevance of canine homologs of conserved longevity genes. Currently, 121 
this may stand as an obstacle in the way of effectively utilizing dogs as aging models. As family dogs 122 
can provide unique insights into many aspects of human aging, the current lack of detailed 123 
information about the canine genetic pathways of aging should be overcome by future research 124 
approaches. In this review we provide an overview of the evolutionary conserved biological 125 
mechanisms that contribute to aging, following the classification system proposed by Lopez-Otin et 126 
al. in 2013, and we summarize current knowledge about these pathways in dogs. We also briefly 127 
discuss the benefits and limitations of family dogs in aging research and propose possible future 128 
directions for canine aging genetic studies. 129 
 130 
Dogs as model animals in aging research 131 
 132 
A plethora of different species has been involved in aging studies to unravel the genetic factors behind 133 
this complex biological process. Due to their short lifespan and easy handling under laboratory 134 
conditions, the yeast (Saccharomyces cerevisiae), the nematode worm Caenorhabditis elegans, the 135 
fruit fly (Drosophila melanogaster) and rodents (mice – Mus musculus and rats – Rattus norvegicus) 136 
all became important contributors to the discovery of longevity affecting genes. Recently, the 137 
turquoise killifish (Nothobranchius furzeri) has also been added to this palette (Hu and Brunet, 2018). 138 
The applicability of various genetic approaches (e.g. induced mutagenesis, RNA interference, gene 139 
trapping) in these organisms allowed researchers to specifically target genes for further investigations 140 
or to efficiently search for phenotype-genotype associations in mutants.  141 
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As most of the revealed pathways turned out to be highly conserved, findings made on model 142 
organisms seemed translatable to humans in most cases. However, human aging has characteristics, 143 
like the occurrence of age-related dementia, which do not have counterparts in many model 144 
organisms. Although, this limitation has been overcome by different techniques to induce 145 
neurodegenerative processes in the central nervous system (CNS) of model animals, the findings of 146 
such studies may not be easily implemented in humans (De Felice and Munoz, 2016; Jucker, 2010; 147 
Puzzo et al., 2015). In addition, the interaction between genetic factors and environmental conditions 148 
can also vary in humans, meaning that certain variants can have beneficial effects in one context and 149 
adverse effects in another (Ukraintseva et al., 2016). 150 
Therefore, studies on human populations are inevitable to understand human aging in its full 151 
complexity. Apparently, in this case the genetic toolkit is reduced to associative approaches. With the 152 
advent of the genomic era this has become less of a problem, and several GWAS studies have actually 153 
reported lifespan affecting loci in humans (Beekman et al., 2013; Deelen et al., 2011; Nebel et al., 154 
2011; Sebastiani et al., 2012; Sebastiani and Perls, 2012). However, longitudinal studies and testing 155 
the effects of anti-aging interventions are still more challenging in humans than in short lived animals. 156 
When all of these considerations are taken into account, the dog may rise as an excellent midline 157 
solution for the limitations of simple organisms and for the challenges human studies hold (Waters, 158 
2011). Here are some examples, why:  159 
1. Family dogs, on average, age about six-seven times faster than humans. The mean lifespan of 160 
companion dogs (purebred and crossbred together) from Europe and Japan were shown to be 161 
12 and 13.7 years, respectively (Inoue et al., 2018; O’Neill et al., 2013), while the mean 162 
lifespan of European humans is 77.2, according to a UN report (Anon, 2019) and is around 83 163 
years for Japanese people (Tokudome et al., 2016). Therefore, follow-up studies are much 164 
easier in the case of dogs, and have already been performed by several research groups to 165 
measure immunological, neuropathological and metabolomic changes related to canine aging 166 
(Cotman and Head, 2008; Greeley et al., 2006; Su et al., 2005).  167 
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2. The fact that the mean lifespan of dogs can range from 5.5 to 14.5 years (Jimenez, 2016; 168 
Michell, 1999; O’Neill et al., 2013), depending on body size and breed, suggests that dogs, 169 
sharing their lives with humans, gained considerable advantages from this alliance by 170 
doubling their mean expected life span compared to wild wolves (Mech, 2006). This 171 
artificially enhances the proportion of individuals with age-related pathologies, which often 172 
show strong correspondences with human diseases, and thus can provide opportunities for 173 
translational studies.  174 
3. Dogs are prone to develop human-like neurodegenerative disorders, and are susceptible to age 175 
related cognitive abnormalities. Almost one third of 11-12-year-old dogs and 70% of 15-16-176 
year-old dogs were reported to show cognitive disturbances with symptoms corresponding to 177 
human senile dementia: spatial disorientation, social behavior disorders (e.g. problems with 178 
recognizing family members), repetitive (stereotype) behavior, apathy, increased irritability, 179 
sleep-wake cycle disruption, incontinence, and reduced ability to accomplish tasks (Neilson et 180 
al., 2001). Together, these symptoms constitute a typical, age-related, progressive 181 
pathological decline in dogs’ mental abilities, which is usually referred to as “Canine 182 
Cognitive Dysfunction Syndrome” (CCD) (Cummings et al., 1996; Landsberg et al., 2012). 183 
To this day, a vast amount of literature has accumulated about CCD (Chapagain et al., 2018; 184 
Szabó et al., 2016), yet there is weak knowledge about the genetic factors influencing it. 185 
Importantly, cognitive decline in dogs was associated with β-amyloid accumulation in the 186 
prefrontal cortex, noradrenergic neuron loss in the locus coeruleus (Insua et al., 2010) and, 187 
lately, with the formation of tau tangles (Schmidt et al., 2015; Smolek et al., 2016), which can 188 
all be seen in humans in early stages of neurodegenerative diseases.  189 
4. Dogs also correspond very well to humans in several metabolic and physiological features, 190 
some of which are consequences of domestication (Axelsson et al., 2013). These features 191 
have already been thoroughly described in laboratory dogs, as traditional test animals of the 192 
pharmacological industry. Therefore, the intestinal absorption profiles of many drugs and 193 
supplements are actually known to be very similar in dogs and humans (Roudebush et al., 194 
2005). 195 
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5. Several studies from the last two decades (for a review on the history of dog behavioral 196 
research see Feuerbacher and Wynne, 2011) have supported the notion that dogs possess 197 
cognitive abilities that are similar to human social skills in communication and learning 198 
(Bensky et al., 2013; Miklósi, 2014; Topál et al., 2009). Also, they have a prolonged postnatal 199 
period with high sensitivity for human contact and usually live in a close proximity with 200 
people, which makes them able to easily interpret many human actions (Miklósi and Kubinyi, 201 
2016). Therefore, dogs can participate in special experimental protocols, which would not be 202 
possible with less trainable and sociable species.  203 
6. Dogs share more ancestral genomic sequence with humans than rodents do (Lindblad-Toh et 204 
al., 2005) and linkage disequilibrium regions can be extensive within dog breeds, making it 205 
easier to pinpoint phenotype – marker associations, which can be later narrowed down by 206 
interbreed investigations. This provides particular prospects for GWAS studies (Boyko, 2011; 207 
Hayward et al., 2016; Schoenebeck and Ostrander, 2014; Vaysse et al., 2011).  208 
7. Family dogs are plentiful and easily available at very little cost, so large datasets can be 209 
collected via the help of dog owners and veterinarians under citizen science approaches 210 
(Hecht and Rice, 2015; Stewart et al., 2015). 211 
These points suggest that family dogs can become valuable models to study complex human traits like 212 
aging. However, researchers have to face some obstacles and limitations as well, which have to be 213 
addressed properly. 214 
1. One of these limitations is the still deficient knowledge about the exact functions that 215 
conserved genetic pathways play in canine aging. On the one hand, this may seem to be a 216 
minor question, as all fundamental cellular senescence mechanisms were reported to be 217 
conserved. On the other hand, divergences may occur in each species regarding some of these 218 
mechanisms, as for example, both the telomere biology of flies and the somatic telomerase 219 
expression of mice were reported to show marked differences from humans (Kipling and 220 
Cooke, 1990; Levis et al., 1993; Prowse and Greidert, 1995). Furthermore, the genes and their 221 
functions linked to human age-related neurodegeneration may be fundamentally different 222 
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from their homologs found in model organisms, or even missing from other species (Bitar and 223 
Barry, 2017). Consequently, in an ideal setting, each genetic pathway should be evaluated in 224 
each species intended for translational studies before further efforts are put into costly and 225 
time-consuming investigations.  226 
2. The variable living environment of family dogs has been discussed as a potential advantage 227 
over laboratory dogs, however, it also brings serious challenges to optimal study design. 228 
Integrative and cooperative approaches based on large datasets could help to overcome this 229 
limitation. Large-scale retrospective studies, which were based on veterinary databases, have 230 
already led to important findings regarding the differences in life expectancies between 231 
various breeds (Inoue et al., 2018; O’Neill et al., 2013; Proschowsky et al., 2003), or between 232 
lean and obese dogs (Salt et al., 2018). In this regard, citizen science approaches can have 233 
promising prospects in family dog research (Hecht and Rice, 2015; Stewart et al., 2015), as it 234 
was already indicated by a few examples (Hecht and Rice, 2015; Ilska et al., 2017; Stewart et 235 
al., 2015). Also, if studies need to involve pathological, histological and molecular data about 236 
dogs that suffered from CCD, citizen science approaches must be expanded to involve a wider 237 
range of professionals, including veterinarians. Such interdisciplinary studies may become 238 
especially important in cases where family dogs are used as pre-clinical models to test the 239 
anti-aging effects of drugs (Kaeberlein et al., 2016). 240 
3. Until now few studies involved family dogs in cellular and molecular level investigations, as 241 
this may require invasive methods or even the sacrifice of animals. Apparently, such 242 
approaches are not applicable in the case of family dogs, which however, represent the 243 
valuable genetic and behavioral variability of the species. These issues were encountered by 244 
researchers, who aimed to study brains of non-laboratory dogs, and found it difficult to collect 245 
both behavioral and molecular data (which required medically advised euthanasia of the 246 
animals) from the same individuals within the time-frame of the study (Ghi et al., 2009). In 247 
this regard, the establishment and long-term maintenance of databanks and biobanks that 248 
collect behavioral, lifestyle, medical data and biological materials from family dogs, by 249 
providing the opportunity for owners to donate their dogs’ bodies for research purposes under 250 
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appropriate ethical considerations, would be advantageous for canine genomics and aging 251 
research. 252 
4. Similarly to invasive methods, genetic manipulations may seem less applicable in dogs, than 253 
in experimental model organisms. Nevertheless, some groups have already applied targeted 254 
genetic manipulations in laboratory dogs to create better models of certain medical conditions 255 
(Zou et al., 2015). More importantly, therapeutic applications of gene-editing have recently 256 
been applied on pet dogs suffering from Duchenne muscular atrophy, with promising results 257 
(Amoasii et al., 2018). Hence, it is likely that this line of canine genetics and medical research 258 
will continue to unfold its potentials.  259 
5. Currently, methods, by which cognitive aging can be effectively assessed in dogs, are limited. 260 
Effective phenotypical categorization of canine age-related pathologies, including CCD, will 261 
be crucial for studies, which intend to assess the effects of anti-aging interventions on dogs. 262 
 263 
The hallmarks of aging in dogs 264 
Most aging related genes are components of essential metabolic and signaling pathways (Fig. 1), like 265 
the ones regulating autophagic activity. Other genes make contribution to cellular processes that affect 266 
genomic integrity, either in a protective role (DNA repair mechanisms) or in a destructive manner 267 
(oxidative stress, transposons). Some genes may affect aging in a somewhat programmed manner, 268 
either through epigenetic modulations or by the altered maintenance of telomeres. Because of this 269 
large number of involved genetic – and environmental – factors, establishment of a conceptual 270 
framework that can systematically comprise all of them, would be a first step to provide better insight 271 
into the aging process in its entirety. In this regard, recently nine main factors have been designated as 272 
fundamental hallmarks that contribute to the aging of animals, with a main focus on mammals 273 
(López-Otín et al., 2013). Each hallmark had to meet three criteria: they must affect longevity and 274 
healthspan either in a negative or positive manner and have to show age-related changes in 275 
measurable parameters. Thus, the following phenomena were defined as main contributors to 276 
mammalian aging (Fig. 1): 1. genomic instability; 2. telomere attrition; 3. epigenetic alterations; 4. 277 
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disruption of proteostasis; 5. deregulation of nutrient sensing; 6. mitochondrial dysfunction; 7. cellular 278 
senescence; 8. stem cell exhaustion and 9. altered intercellular communication. Although some of 279 
these could not perfectly fit all of the criteria, they still make an effective framework to work with. 280 
Providing a systematic overview of the genetic pathways involved in the aging of dogs is also of high 281 
relevance, as it can help defining directions in canine aging research to support the progression of the 282 
species into an effective translational model. For example, in the case of the apolipoprotein E (APOE) 283 
gene, which has polymorphisms strongly associated with average lifespan and Alzheimer’s risk in 284 
humans (Broer et al., 2015; Nebel et al., 2011), the translational relevance of the canine homolog is 285 
debatable, because APOE's sequence was reported to have low conservation between the two species 286 
(Sarasa et al., 2010). Nevertheless, the function of the expressed protein may still be conserved. As 287 
APOE variants are major risk factors of human dementia, clarifying this question would be an 288 
important step to ensure clinical translatability of canine CCD research. In general, exploring more 289 
details about genetic pathways and gene variants involved in canine aging and age-related pathologies 290 
should be a major consideration of researchers who utilize dogs in aging research.  291 
 292 
Genomic instability 293 
 294 
As organisms age, various forms of damage may accumulate in their genomes, leading to mutations, 295 
chromosomal rearrangements and aneuploidy (Faggioli et al., 2012; Forsberg et al., 2012; Moskalev 296 
et al., 2013). Increased mutational burden in somatic cells eventually hinder cellular function and lead 297 
to terminal cellular senescence or apoptosis. In cases, when cells escape death / senescence inducing 298 
processes, malignant transformations can occur as a consequence of genomic damage. Therefore, 299 
various protective mechanisms have evolved to prevent or correct DNA damage. Genomic instability 300 
arises when the occurrence of deleterious events exceeds the capacity of the DNA damage response 301 
system. DNA damaging agents can originate from various extrinsic or intrinsic sources. Intrinsic 302 
factors involve oxidative damage, telomere attrition and transposon insertions. 303 
 304 
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The DNA Repair Machinery 305 
 306 
The DNA repair machinery involves divergent pathways, each aimed to correct certain forms of DNA 307 
damage (Fig. 2). These protective mechanisms have been in the focus of cancer and aging research for 308 
a long time (Cho and Suh, 2014; Lombard et al., 2005; Zimmermann, 1971). Defects in DNA repair 309 
genes, like the Bloom syndrome RecQ like helicase (BLM) and the Werner syndrome RecQ like 310 
helicase (WRN), can lead to severe illnesses, called progeria syndromes in humans, which are 311 
characterized by premature aging and other symptoms, including cognitive disabilities and a higher 312 
rate of tumorigenesis (Arora et al., 2014; Ellis et al., 1995; Martin, 2005; Yu et al., 1996). Mutations 313 
in other DNA repair genes were also reported to increase cancer risk (Jeggo et al., 2016) and thus lead 314 
to a reduction in expected lifespan. More importantly, polymorphisms in several genes of the DNA 315 
damage response machinery have been actually linked to longevity in humans (Cho and Suh, 2014). 316 
Intriguingly, no canine progeria syndrome has been documented in scientific literature. On the other 317 
hand, several studies that investigated various forms of canine cancer revealed alterations in the DNA 318 
repair machinery, which corresponded to findings in human cancers. For example, a reduced DNA 319 
damage response capacity was observed in lymphomas of Golden retriever dogs (Thamm et al., 2013) 320 
and a lower expression of the ATM serine/threonine kinase (ATM) gene was found in canine 321 
mammary tumors (Raposo-Ferreira et al., 2016). Genetic variations in the breast cancer 1 (BRCA1) 322 
and tumor protein p53 (TP53) genes and the MTAP-CDKN2A locus were also linked to various forms 323 
of cancer in dogs (Kirpensteijn et al., 2008; Rivera et al., 2009; Shearin et al., 2012). Meanwhile these 324 
findings clearly promote the dog as a natural model of human cancers, it is still unclear, how exactly 325 
variations in DNA repair capacity contribute to the expected lifespan of dogs. A more detailed 326 
discussion of DNA repair in dogs can be found in the review of Grosse et al., (2014).  327 
 328 
Nuclear architecture 329 
 330 
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Genomic instability may also rise from altered nuclear architecture. Good examples are the 331 
Hutchinson-Gilford and the Néstor-Guillermo progeria syndromes, which were linked to mutations in 332 
lamin genes responsible for formation of the nuclear lamina (Cabanillas et al., 2011; De Sandre-333 
Giovannoli et al., 2003; Eriksson et al., 2003). In addition, both the accumulation of progerin, which 334 
is an aberrant form of lamin A, and the reduced expression of lamin B1 were linked to aging (Freund 335 
et al., 2012; Golubtsova et al., 2016; Hilton et al., 2017) and lamins were also shown to regulate DNA 336 
damage response (Gonzalez-Suarez et al., 2009). Thus, the canine homologs of lamins could be 337 
promising targets in aging research. So far, a few studies have investigated them, mainly in regard to 338 
their possible role in hereditary diseases, like dilated cardiomyopathy of Doberman pinschers and 339 
Newfoundland dogs (Meurs et al., 2008; Wiersma et al., 2007) and elbow dysplasia in Bernese 340 
Mountain Dogs (Pfahler and Distl, 2012), however only in the latter case an association was reported 341 
between disease occurrence and the lamin B1 gene.  342 
 343 
Oxidative damage 344 
 345 
Oxidative damage in cells mainly results from chemical interactions between cellular constituents and 346 
reactive oxygen species (ROS), which chemically act as free radicals, characterized by a high 347 
oxidative activity. These agents target macromolecules, such as DNA, lipids (Rubbo et al., 1994) and 348 
proteins (Stadtman and Levine, 2006), and thus may make a huge impact on cellular function. The 349 
sources of ROS are many: mitochondrial respiration (Liu et al., 2002; Murphy, 2009), ionizing 350 
radiation (Riley, 1994) and the activity of specific enzymes, such as the NADPH oxidase (Babior, 351 
2004) and dual oxidase (DUOX) (Edens et al., 2001), are the main examples.  352 
The amount of oxidative DNA lesions has been well documented to increase with age in different 353 
species. For example, in rats Fraga et al. (1990) reported the age-related accumulation of 8-hydroxy-354 
2-deoxyguanosine, which is a typical product of DNA oxidation. Furthermore, several studies 355 
confirmed that aged dogs show elevated levels of oxidative damage in their brains, indicated by the 356 
accumulation of carbonyl groups (Head et al., 2002; Skoumalova et al., 2003), lipofuscin (Rofina et 357 
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al., 2004), 4-hydroxynonenal (Hwang et al., 2008; Papaioannou et al., 2001; Rofina et al., 2004) and 358 
malondialdehyde (Head et al., 2002) in neural tissue. In addition, as the reduced expression of 359 
antioxidant enzymes may also contribute to the increased oxidative burden in cells (Kiatipattanasakul 360 
et al., 1996), their role in neural aging and neurodegeneration should also be considered. In humans, 361 
for example, a mutation in superoxide dismutase 1 (SOD1), which is a main antioxidant enzyme in 362 
cells, has been linked to amyotrophic lateral sclerosis (ALS) (Orrell, 2000). Importantly, a mutation in 363 
the canine homolog of SOD1 was also linked to an ALS like neurodegenerative process, called 364 
degenerative myelopathy (DM) (Awano et al., 2009). 365 
Surprisingly, ROS have also been indicated as important and evolutionary conserved signaling 366 
molecules, which function in pathways that respond to availability of nutrients, changes in 367 
environmental oxygen levels and exercise (Merry and Ristow, 2016; Schieber and Chandel, 2014). 368 
Hydrogen peroxide (H2O2) for example, plays an important role as signal transducer in the MAPK and 369 
Nf-Kβ pathways (Allen and Tresini, 2000) and also serves as activator of peroxiredoxins (Wood et al., 370 
2003), which are crucial for maintaining redox balance of cells. Nitric oxide (NO) has long been 371 
indicated to play various physiological roles, with emphasis on the immune and cardiovascular 372 
systems (Lundberg et al., 2008). Thus, maintaining optimal levels of oxidative stress in cells could 373 
actually be more important for healthy aging, than maximizing the neutralization of ROS by 374 
antioxidants. In accordance with this, some studies reported controversial effects of oxidative stress in 375 
aging and metabolic parameters. For example, it was demonstrated by Ristow et al. in 2009 in a 376 
human study, that supplementation with high doses of extrinsic antioxidants ameliorated the 377 
beneficial effects of exercise in volunteers. Furthermore, elevated levels of ROS were reported to 378 
either increase lifespan in yeast and worms (Doonan et al., 2008; Mesquita et al., 2010; Van 379 
Raamsdonk and Hekimi, 2009) while having no effect on mortality in mice (Van Remmen et al., 380 
2003; Zhang et al., 2009). Also, the lifespan extension of worms promoted by reduced glucose 381 
availability was found to be accompanied by elevated levels of ROS in cells (Schulz et al., 2007). 382 
Such findings led to the reconsideration of the role oxidative stress plays in cellular senescence and 383 
resulted in a more refined view (López-Otín et al., 2013; Shadel and Horvath, 2015). In this regard, it 384 
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is a question yet to be addressed, how lifelong antioxidant supplementation, often provided by high-385 
quality commercial foods, may affect the healthspan of dogs. 386 
 387 
Transposable elements 388 
 389 
The mobilization of endogenous transposable elements, called transposons, has recently gained 390 
attention as an intrinsic contributor to cellular senescence (Gorbunova et al., 2014). Transposons are 391 
present in the genomes of all organisms, from bacteria to mammals, and possess the ability to change 392 
their position in or between chromosomes. They can be categorized into two groups. Retrotransposons 393 
move by a replicative “copy and paste” mechanism, increasing in numbers in their host genome (Fig. 394 
3), while DNA transposons mainly follow a “cut and paste” mechanism, leaving only a short footprint 395 
behind (Mandal and Kazazian, 2008; Wicker et al., 2007). Since the human genome project revealed 396 
that around 55% of the human genome is composed of remains of transposable elements, mainly of 397 
retrotransposons, an increased attention has been paid to their role in genome evolution (Kazazian, 398 
2004), especially in the formation of gene regulatory networks (Sundaram et al., 2014). While all 399 
DNA transposons have lost their mobility in the course of human evolution (Pace and Feschotte, 400 
2007), several retroelements found in our genome are still active, and can cause insertional mutations 401 
(Hancks and Kazazian, 2016). Human retroelements can be categorized into three groups: the LTR 402 
(Long Terminal Repeat) elements, the LINE (Long Interspersed Nuclear Element) transposons and the 403 
SINE (Short Interspersed Nuclear Element) transposons (Mandal and Kazazian, 2008). Similar types 404 
of retroelements can be found in the dog genome, however transposon-derived sequences make up 405 
only 34% of it (Lindblad-Toh et al., 2005). Importantly, active LINE and SINE elements are present in 406 
both species.  407 
Active retroelements have been found responsible for several hereditary diseases in dogs, by causing 408 
insertional mutations. For example, a LINE-1 (L1) insertion in the gene of Factor IX was shown to 409 
segregate with mild hemophilia in German Wirehaired Pointers (Brooks et al., 2003), while a similar 410 
insertion in the dystrophin gene leads to Duchenne-like muscular dystrophy in Pembroke Welsh Corgi 411 
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dogs (Smith et al., 2011). SINE elements were also shown to cause several inherited diseases, like 412 
recessive centronuclear myopathy in Labrador Retrievers (Tiret et al., 2005) and early canine retinal 413 
degeneration, which was linked to the serine/threonine kinase 38 like (STK38L) gene in Norwegian 414 
Elkhound – Beagle outcrosses by linkage mapping, (Goldstein et al., 2010). A form of progressive 415 
retinal atrophy (PRA) in Tibetan Spaniels and Tibetan Terriers was also associated with a SINE 416 
insertion, but in the family with sequence similarity 161 member A (FAM161A) gene (Downs et al., 417 
2014). Bandera’s neonatal ataxia in Coton de Tulear dogs was shown to be caused by the disruption 418 
of the glutamate metabotropic receptor 1 (GRM1) gene by recent retrotransposon mobilization, as the 419 
insertion was not found in other breeds (Zeng et al., 2011). Interestingly, several examples of non-420 
disease causing insertional mutations are known, which alter morphology (Marchant et al., 2017; 421 
Parker et al., 2009), or coat color (Clark et al., 2006; Dreger and Schmutz, 2011) and thus have 422 
become selection criteria in many breeds. Beyond these examples, where the integration event can be 423 
revealed by a phenotypic effect or disease, the mobilization of retroelements seems common in dogs, 424 
as analyses of individual dog genomes showed that approximately half of annotated dog genes contain 425 
a SINEC_Cf type insertion in their introns (Wang and Kirkness, 2005). This high activity of 426 
retrotransposons in the lineage of domestic dogs can be explained by intense selection pressures that 427 
resulted from domestication, breeding strategies and changing environment (Capy et al., 2000; 428 
Chénais et al., 2012). This hypothesis was actually supported by the findings of Koch et al. (2016), 429 
who compared the methylation patterns of wolf and dog genomes and found that almost half of the 430 
sites potentially relevant in domestication contained a LINE or SINE insertion.  431 
Beyond the germ-line mutations discussed so far, a vast body of evidence indicates that retroelements 432 
can mobilize in somatic cells (Collier and Largaespada, 2007; Hunter et al., 2015) although this is 433 
strictly controlled by specific non-coding small RNAs and epigenetic regulation, including 434 
hypermethylation and transcriptional repression (Levin and Moran, 2011; Pizarro and Cristofari, 435 
2016). As the general hypomethylation of the genome has long been documented to be an attribute of 436 
aging (Singhal et al., 1987; Wilson and Jones, 1983), more and more researchers have suggested a 437 
main role for somatic transposon mobilization in cellular senescence (Murray, 1990; Pal and Tyler, 438 
2016; Sturm et al., 2015). Importantly, this hypothesis was also supported by experimental findings. 439 
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For example, the artificial downregulation of the yeast Ty1 element resulted in lower levels of age-440 
related chromosome rearrangements in aged cells (Maxwell et al., 2011). Also, many of the 118 L1 441 
subfamilies of mice showed an elevated expression with age (De Cecco et al., 2013). In humans the 442 
hypomethylation of LINE-1 and Alu (a SINE element abundant in the human genome) elements have 443 
been linked to cancer susceptibility (Luo et al., 2014; Zhu et al., 2011).  444 
Because the activation of transposable elements can be induced by various environmental stressors as 445 
well (Hunter et al., 2015), including heavy metal toxicity (Morales et al., 2015), certain genotoxic 446 
agents (Stribinskis and Ramos, 2006) and even nutrition (Waterland and Jirtle, 2003), they represent 447 
another possible intracellular interface between the living environment / lifestyle and aging. In this 448 
regard, family dogs, which share their environment with their owners, can be valuable models to 449 
study how retrotransposons may contribute to aging and mortality under various circumstances. The 450 
age-related activity of retroelements has not yet been specifically assessed in dogs. However, in a 451 
study, which investigated the elevated blood levels of SINE sequences in dogs with mammary tumors, 452 
it was shown that tumor-affected dogs above 10 years of age had higher levels of circulating SINE 453 
elements than younger dogs with tumors (Gelaleti et al., 2014).  454 
 455 
Telomere attrition and aging 456 
 457 
In most eukaryotic cells, shortening of the protective sequences at chromosome ends (Fig. 4/A), called 458 
telomeres, occurs with each DNA replication. Therefore, telomere shortening has been proposed as a 459 
key mechanism of cellular senescence and it also suggested the existence of an aging program in cells 460 
(Harley et al., 1990; Hastie et al., 1990; Shampay and Blackburn, 1988). This so called replicative 461 
aging limits the number of cell cycles a cell can go through before reaching its Hayflick limit and 462 
entering a senescent state (Hayflick, 1976). Furthermore, a recent study supported the conserved role 463 
of this aging program on the level of whole organisms by reporting clear correlations between the rate 464 
of telomere shortening and the lifespan of different mammalian and bird species (Whittemore et al., 465 
2019). Importantly, telomere shortening is a characteristic only of somatic cells, while in germ line 466 
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cells telomere sequences are constantly restored by telomerase enzymes. The limited proliferative 467 
potential of somatic cells may seem disadvantageous for an individual, yet it may increase fitness by 468 
limiting the growth of malignant cells. In line with this, recent studies have suggested a trade-off 469 
between telomere length and cancer occurrence (Stone et al., 2016; Zhang et al., 2015). On the other 470 
hand, loss of telomeres can result in end-to-end chromosomal fusions, which might also lead to 471 
tumorigenesis (Hastie et al., 1990). These findings indicated that fine tuning of telomere dynamics in 472 
somatic cells might be crucial for healthy aging, at the cost of reducing the maximal lifespan. In fact, 473 
polymorphisms in genes associated with telomerase function were shown to be linked with expected 474 
lifespan and disease predisposition in human populations (Atzmon et al., 2009; Codd et al., 2013; 475 
Soerensen et al., 2012b). Telomere dynamics may also play an influential role in neurodegeneration, 476 
as patients with Alzheimer’s showed shorter average telomere length than healthy controls (Forero et 477 
al., 2016). Therefore, understanding the links between telomeres and age-related changes on the 478 
cellular level, which can lead to pathological processes, is a main goal in aging research. However, in 479 
some animals, including common laboratory models, telomerase biology does not entirely correspond 480 
to that described in humans. The laboratory mouse, for instance, was shown to exhibit a high 481 
variability of telomere length and telomerase expression in adult tissues (Greenberg et al., 1998; 482 
Kipling and Cooke, 1990; Martín-Rivera et al., 1998; Prowse and Greidert, 1995), indicating a lesser 483 
role of constant telomere attrition as a programmed aging inducer. More importantly, D. melanogaster 484 
was shown to possess a fundamentally different telomere structure than found in other animals, as 485 
chromosome ends of fruit flies are capped by transposon derived sequences (Levis et al., 1993). These 486 
facts clearly limit the applicability of these species as models of human telomere function 487 
(Smogorzewska and De Lange, 2002; Wright and Shay, 2000). Nevertheless, longevity of mice was 488 
still shown to be positively affected by gene therapy induced telomerase expression (de Jesus et al., 489 
2012).  490 
Contrary to mice, dogs were reported to have low or no telomerase expression in normal somatic 491 
tissues, a pattern similar to that in humans (Nasir et al., 2001). It was also reported by Yazawa et al. 492 
(1999, 2001). Furthermore, tumors in dogs often showed high levels of telomerase expression, 493 
similarly to human malignancies (Lamb et al., 2015; Vonderheide et al., 1999). Although very little is 494 
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known about the molecular mechanisms regulating telomere maintenance and cell cycle arrest in 495 
dogs, such findings indicate that dogs may also share basic telomere biology with humans. 496 
Importantly, telomere length was shown to be variable across different dog breeds and was in 497 
correlation with expected lifespan (Fick et al., 2012). Also, telomere length in individual dogs were 498 
found to decrease with age (Nasir et al., 2001), similarly as described in humans (Harley et al., 1990; 499 
Hastie et al., 1990; Lindsey et al., 1991). 500 
 501 
Epigenetic alterations 502 
 503 
Epigenetics refers to mechanisms, which modulate gene expression by determining how the 504 
transcription apparatus can access different sections of the genomic DNA. The condensation 505 
procedure, which literally packs the DNA double helix into a dense structure, called chromatin, is one 506 
of the main mechanisms to provide epigenetic regulatory potentials (Fig. 4/C). The structure of 507 
chromatin is determined by histone proteins, which constitute the basic building blocks for DNA 508 
condensation, the nucleosomes. The more densely packed heterochromatic state renders the DNA 509 
inaccessible for RNA polymerases, and thus inhibits gene expression, while genes positioned in 510 
euchromatic sites are open to transcription. However, not all of these genes can be transcribed, even if 511 
appropriate activating factors are present, as another epigenetic mechanism, the methylation of 512 
cytosines at specific GC-rich sites (called CpG islands) may block transcription (Fig. 4/B). This 513 
process has an important role in cellular differentiation and probably also acts as genomic “memory”, 514 
storing information about the fate of individual cells (Bird, 2002; Halley-Stott and Gurdon, 2013). 515 
Abnormal somatic alterations in DNA methylation have been linked to various diseases, including 516 
schizophrenia (Hannon et al., 2015; Wockner et al., 2015). Furthermore, changes in chromatin 517 
structure and methylation pattern are often found in cancer (Daniel and Tollefsbol, 2015), where the 518 
disruption of cellular identity and concurrent dedifferentiation is a common phenomenon.  519 
Interestingly, the genomic methylation pattern is erased and rewritten during spermato- and oogenesis 520 
and after fertilization in mammals (Geiman and Muegge, 2009; Seisenberger et al., 2012; Smith et al., 521 
2012). The exact role these mechanisms play in aging, however, is still unknown.  522 
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In general, systemic changes in the ratio of heterochromatic and euchromatic regions (Fig. 4/D) and a 523 
global hypomethylation of the genome has been shown to accompany aging (Gentilini et al., 2013; Pal 524 
and Tyler, 2016). When focusing on specific genomic regions, however, both hypomethylation and 525 
hypermethylation should be taken into account (Maegawa et al., 2010). Actually, senescence related 526 
changes in the DNA methylation profile may include both the activation of pro-aging genes and the 527 
repression of anti-aging genes, as in the case of WRN and LMNA (Fraga and Esteller, 2007). The 528 
remodeling of chromatin structure, induced by methylation and acetylation of certain histone protein 529 
residues, also shows complex age-related patterns (Fraga and Esteller, 2007; Han and Brunet, 2012). 530 
Importantly, both chromatin dynamics and DNA methylation were shown to interact with other age-531 
related genetic pathways, like telomere-length control (Blasco, 2007). In turn, the telomerase enzyme 532 
was found to affect chromatin structure and DNA repair mechanisms (Masutomi et al., 2005). In 533 
addition, the epigenetic pattern is regulated by many factors other than developmental status, like 534 
stress, exercise and diet (Daniel and Tollefsbol, 2015), which therefore can also affect aging through 535 
altering the expression of certain genes. 536 
Although age associated changes in chromatin structure and DNA methylation patterns have been 537 
reported in several model animals, there can be major differences between species. For example, 538 
epigenetic regulation in C. elegans seems to be limited to chromatin remodeling by histone 539 
modifications, as m5C DNA methylation pattern does not exist in this organism (Bird et al. 2002), 540 
limiting its utilization as a model to study epigenetic changes in aging. Nevertheless, the histone 541 
demethylase UTX-1 was shown to regulate aging in worms (Jin et al., 2011).  542 
In dogs, an increasing body of evidence has suggested epigenetic regulation behind species and breed 543 
specific traits (Banlaki et al., 2017; Cimarelli et al., 2017; Koch et al., 2016). Importantly, a recent 544 
study demonstrated that changes in methylation status in DNA regions, which were homologous to 545 
regions with known age sensitive methylation patterns in humans, were in strong correlation with 546 
chronological age in dogs and wolves (Thompson et al., 2017). This finding supported the 547 
applicability of the dog as a model of age-related epigenetic changes, while it also provided a 548 
molecular approach to determine the biological age of individual canines. 549 
 550 
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Regulation of epigenetic pattern 551 
 552 
The regulation and maintenance of the epigenetic pattern is coordinated by various enzymes, which 553 
act downstream of metabolic and signaling pathways. Altered functions of these enzymes were shown 554 
to have a major impact on health and aging. Most importantly, sirtuin genes were among the first 555 
shown to affect longevity in yeast (Kaeberlein et al., 1999), C. elegans (Tissenbaum and Guarente, 556 
2001), Drosophila (Rogina and Helfand, 2004) and mice (Calvanese et al., 2009). Sirtuins exert 557 
various enzymatic functions, including histone deacetylation, and thus play a key role in the 558 
maintenance of chromatin structure (Fraga and Esteller, 2007; Longo and Kennedy, 2006). They also 559 
interact with many signaling and metabolic pathways, regulate oxidative metabolism, stress response, 560 
autophagy and the maintenance of telomeres (Jia et al., 2012; Kim et al., 2012). In mammals, 7 561 
sirtuins are known with divergent functions (Guarente, 2011) and at least three of them – SIRT1, 562 
SIRT3, SIRT6 – have been implicated to modulate aging. Importantly, polymorphisms in sirtuin genes 563 
have been actually linked to human longevity (Albani et al., 2014; Kim et al., 2012).  564 
Sirtuins and other histone modifying enzymes, together with DNA methyltransferases, have been 565 
barely studied in dogs so far. However, as the sequence and function of sirtuin genes show a highly 566 
conserved nature (Gaur et al., 2017; Greiss and Gartner, 2009) they are likely to play similar roles in 567 
the aging of dogs as in other species. In fact, altered expression of sirtuin genes, mainly that of SIRT1 568 
have been implicated in canine tumors (Marfe et al., 2012), similarly as in humans (Brooks and Gu, 569 
2009). Several sirtuin-targeting drugs have been proposed as promising pharmacological interventions 570 
to fight disease and aging (Dai et al., 2018), therefore they are likely to be utilized in the future as 571 
anti-aging therapeutics and may be applied in dogs as well. In this regard, some compounds that 572 
interact with histone regulating enzymes have already been tested in dogs for various reasons. For 573 
example, the histone deacetylase inhibitors AR-42 and panobiostat showed promising results in dog 574 
cell line models of prostate cancer and B-cell lymphoma, respectively (Dias et al., 2018; Elshafae et 575 
al., 2017). More importantly, resveratrol, which has sirtuin activating effect (Gertz et al., 2012), was 576 
reported to positively affect the immune function of healthy pet dogs (Mathew et al., 2018) and it also 577 
effectively inhibited the growth of canine hemangiosarcoma in vitro (Alderete et al., 2017). Actually, 578 
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resveratrol is one of the most comprehensively studied naturally occurring compounds with suggested 579 
beneficial effects on health and aging. It was shown to activate SIRT1 and improve mitochondrial 580 
function in mice (Lagouge et al., 2006) and to reverse age-related cognitive decline in learning and 581 
memory in rats (Gocmez et al., 2016). However, its longevity benefits are still dubious. For example, 582 
it only increased the relative survival of mice when the animals received a high calorie diet (Baur et 583 
al., 2006). Longitudinal follow-up studies on family dogs may help to clarify this question, as these 584 
animals represent a naturally variable population regarding diet and genetic background. 585 
 586 
Age-related changes in gene expression 587 
 588 
Alterations in the epigenetic pattern, together with the availability of transcription factors and 589 
activation of signaling pathways, can influence the whole expressed mRNA content (the 590 
transcriptome) in cells. Not surprisingly, altered gene expression patterns were shown to correlate 591 
with aging in mice, humans and dogs (Lee et al., 1999, 2000; Lu et al., 2004; Swanson et al., 2009; 592 
Zahn et al., 2007). Comparisons between species-specific expression profiles have already been 593 
implicated as powerful tools to identify evolutionary conserved regulatory pathways (de Magalhães et 594 
al., 2009). In this regard, further gene expression data from dogs, especially from individuals with 595 
CCD, may also help researchers to pinpoint the shared molecular pathways of human and canine 596 
neurodegeneration.  597 
The expression of some microRNAs (miRNAs), which are small non-coding RNAs with important 598 
regulatory functions, were also shown to correlate with aging in humans and mice (Drummond et al., 599 
2011; Inukai et al., 2012; Somel et al., 2010; Zhang et al., 2012). Furthermore, age-associated 600 
miRNAs – named as gero-miRNAs – were identified in various organisms and were shown to target 601 
mRNAs associated with longevity pathways (Gonskikh and Polacek, 2017). Thus, characterization of 602 
gero-miRNAs would be a crucial step in dog aging research to further support the role of the dog as a 603 
translational model of human aging. Efforts have already been made to provide a detailed annotation 604 
of canine miRNAs (Penso-Dolfin et al., 2016), including the establishment of a miRNA tissue atlas in 605 
Beagle dogs (Koenig et al., 2016). 606 
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 607 
Disruption of proteostasis 608 
 609 
Proteins represent the key functional components of cells. The totality of all protein types expressed 610 
simultaneously in a cell is called the proteome. Proteome integrity is indispensable for the optimal 611 
functionality of cells; therefore, several mechanisms have evolved to maintain its homeostasis – called 612 
proteostasis. Impairments in proteostasis can lead to cellular senescence and even severe diseases, 613 
called proteinopathies, which mainly affect the central nervous system and are caused by the 614 
excessive accumulation and aggregation of misfolded proteins (Pievani et al., 2014). Loss of 615 
proteostasis is hypothesized to be a general attribute of aging cells across different taxa (Koga et al., 616 
2011). For example, it was reported to be an early sign of aging in worms (Ben-Zvi et al., 2009) and 617 
to be a characteristic change during both premature and normal aging in mice (Wilson et al., 2015).  618 
Proteostasis is maintained by the orchestrated function of mechanisms, which provide protein quality 619 
control, support the folding of synthesized proteins, protect them from various stressors, and 620 
eventually remove aberrant or senescent proteins from the cell. The folding and stability of proteins is 621 
mainly supervised by so called chaperone proteins, while the efficient removal of unnecessary, 622 
damaged or senescent proteins is handled by two machineries: the ubiquitin-proteasome system (UPS) 623 
and the autophagy-lysosome pathway. 624 
 625 
Chaperones and protein quality control 626 
 627 
Chaperone proteins play an important role in the post-translational maturation of nascent proteins by 628 
facilitating their folding. They also function as protectors of mature proteins under various stressful 629 
conditions, by helping to maintain their natural conformation and by preventing aggregation. 630 
Actually, the first identified chaperones were named heat shock proteins (Hsp), because their 631 
expression was induced by elevated temperatures. Importantly, many of these stress responsive 632 
chaperones were reported to show reduced expression with aging (Calderwood et al., 2009) and 633 
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genetic manipulations that affected the expression of certain heat shock proteins resulted in altered 634 
aging phenotypes in model organisms. Overexpression or upregulation of Hsp-s were shown to extend 635 
lifespan, together with providing increased stress resistance, in both worms and flies (Chiang et al., 636 
2012; Morrow et al., 2004; Walker and Lithgow, 2003), while reduced chaperone function caused 637 
accelerated aging in mice (Min et al., 2008).  638 
In humans, chaperones, together with other proteostasis maintenance mechanisms, were suggested to 639 
play important roles in neurodegenerative diseases (Morimoto, 2008). This role, however, may not be 640 
entirely protective, as some Hsp-s were actually indicated to augment propagation of malformed 641 
proteins in proteinopathies (Dickey et al., 2007; Luo et al., 2007).  642 
In dogs, the few studies that investigated chaperone proteins in relation to aging reported similar age-643 
related changes as in humans. For example, blood levels of the Hsp70 chaperone were shown to 644 
decrease with age in dogs (Alexander et al., 2018), similarly to what had been previously reported in 645 
humans (Deguchi et al., 1988). Interestingly, a research group, which investigated the hippocampi of 646 
donated pet dogs from various breeds (Ghi et al., 2009), reported an age-related increase in Hsp90 647 
levels. This finding could indicate both a compensatory response to the accumulation of damaged 648 
proteins, and a more direct link between Hsp90 and age-related neural decline in dogs, similarly as it 649 
was suggested in humans, where Hsp90 was implicated as a factor that may actually drive spreading 650 
of taupathy (Dickey et al., 2007; Luo et al., 2007). Based on these possible similarities between canine 651 
and human chaperone functions in the brain, dogs can be suitable to test various pharmacological 652 
interventions and small molecular chaperones (Calamini et al., 2012), which modify or complement 653 
chaperone activity to support proteostasis and reduce neurodegenerative pathologies. Such 654 
interventions have already been successfully tested in rodents (Gehrig et al., 2012).  655 
 656 
The ubiquitin-proteasome system 657 
 658 
The ubiquitin-proteasome system is responsible for the selective removal of misfolded and senescent 659 
proteins in cells. Mutations in genes that encode subunits of the proteasome and proteins responsible 660 
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for proteasomal targeting can lead to accumulation of aberrant proteins, and have been actually linked 661 
to several types of neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease 662 
(Zheng et al., 2016). Especially in the case of AD, causative links were described between 663 
disturbances in the UPS system and progression of the disease (de Vrij et al., 2004; Liu et al., 2014). 664 
Importantly, the UPS system was also linked to longevity in model organisms. In flies, loss-of-665 
function mutations in the ubiquitin activating enzyme E1 were shown to reduce lifespan and cause 666 
disturbances in motor function (Liu and Pfleger, 2013) meanwhile extended lifespan in worms was 667 
associated with increased expression of a proteasome subunit (Vilchez et al., 2012).  668 
In dogs, an increased density of ubiquitinated bodies were reported to be present in the brains of aged 669 
individuals (Borràs et al., 1999; Ferrer et al., 1993), and further signs of impaired proteostasis were 670 
also indicated (reviewed by Romanucci and Della Salda in 2015). The same group that reported age-671 
related increase in the Hsp90 chaperone in dog brains also found incongruent changes in the 672 
abundance of various proteasomal proteins, suggesting complex impairments and compensatory 673 
mechanisms in the regulation of the UPS system in aged dogs (Ghi et al., 2009).  674 
Interestingly, a homozygous lethal mutation in the proteasome β2 subunit was reported as the possible 675 
causative variant behind the unique harlequin coat color of Great Dane dogs (Clark et al., 2011). 676 
Further studies may shed light on the possible health or longevity effects of this mutation.  677 
Importantly, as proteasome activation by pharmacological agents has been proposed as a promising 678 
approach to delay aging and the development of age-related diseases (Chondrogianni et al., 2015), 679 
dogs may provide an appropriate large animal model for pre-clinical testing of these interventions, 680 
especially in the case of brain pathologies.  681 
 682 
Autophagy 683 
 684 
While the ubiquitin-proteasome system eliminates individual proteins or small aggregates tagged by 685 
ubiquitin, the autophagic machinery is capable of targeting greater amounts of cellular content for 686 
lysosomal degradation, including mitochondria and large protein aggregates. In fact, autophagy is a 687 
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fundamental mechanism in eukaryotic cells and was often found indispensable for the ontogenesis of 688 
multicellular organisms, including the embryonic development of mice (Cecconi and Levine, 2008) 689 
and the metamorphosis of flies (Juhász et al., 2003). Three main types of autophagy have been 690 
described in the literature. In the case of macroautophagy, targeted cytoplasmic constituents get 691 
isolated by double membrane vesicles, called autophagosomes. These then fuse with lysosomes, 692 
leading to the degradation of their content into small molecular components (Fig. 5), which can be 693 
recycled thereafter (Klionsky, 2005). The other two types, microautophagy and chaperone-mediated 694 
autophagy, utilize different targeting mechanisms and may be less capable for bulk degradation of 695 
intracellular content. Therefore, the name autophagy usually refers to macroautophagy in the 696 
literature. In general, all types of autophagy play a crucial role in cellular metabolism (Rabinowitz and 697 
White, 2010); pathogen resistance (Deretic, 2006; Levine, 2005); inflammation (Levine et al., 2011); 698 
cleansing of macromolecular debris, like protein aggregates seen in Alzheimer’s disease (Mizushima 699 
et al., 2008; Nixon and Yang, 2011; Rubinsztein, 2006) and in programmed cell death (Ouyang et al., 700 
2012; Tsujimoto and Shimizu, 2005). Impairments in autophagy were linked to several disease 701 
phenotypes in model organisms, as well as in dogs (listed below) and humans (Levine and Kroemer, 702 
2008). Importantly, reduced autophagic activity in the adult brain was shown to promote 703 
neurodegeneration in mice (Hara et al., 2006; Komatsu et al., 2006).  704 
Based on these findings, it is not surprising that autophagy has been proposed as a major factor in 705 
aging regulation. In C. elegans, loss-of-function mutations in autophagy genes shortened lifespan, 706 
while disruption of signaling pathways that downregulate autophagy led to a significant increase in 707 
expected lifespan (Hars et al., 2007; Tóth et al., 2008). Similar findings were reported from yeast, 708 
flies and mice (Eisenberg et al., 2009; Juhász et al., 2007; Pyo et al., 2013; Simonsen et al., 2008), 709 
although with a less pronounced lifespan extension in the latter. Importantly, the longevity effect of 710 
caloric restriction (CR) – which is discussed in the Supplementary section “Beyond genetics” –  was 711 
shown to be dependent on the proper functioning of autophagy (Jia and Levine, 2007). Chaperon-712 
mediated autophagy was also reported to directly affect cellular senescence through the selective 713 
elimination of soluble proteins (Cuervo and Dice, 2000; Massey et al., 2006; Zhang and Cuervo, 714 
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2008). In the livers of aged mice, but not of young animals, impaired function of chaperone-mediated 715 
autophagy resulted in increased loss of proteostasis (Schneider et al., 2015).  716 
Surprisingly, cohort studies have reported little or no association between autophagy linked genes and 717 
longevity in humans, implicating that the effects of mutations, which alter autophagic activity, are less 718 
pronounced, or that such mutations are not common in people. Nevertheless, the role autophagy has in 719 
neurodegenerative processes is indisputable in humans (Jiang and Mizushima, 2014). For example, 720 
mutations in the WD repeat domain 45 (WDR45) gene, which functions in formation of the double 721 
membrane structures (“phagophores”), were shown to cause static encephalopathy of childhood with 722 
neurodegeneration in adulthood (SENDA). Also, both Alzheimer’s and Parkinson’s disease were 723 
characterized by accumulation of autophagic vacuoles, indicating a disruption in their turnover (Nixon 724 
et al., 2005; Nixon and Yang, 2011). Consonantly, loss-of-function mutations in the Parkinson’s 725 
disease associated protein DJ-1 gene were linked to reduced basal levels of autophagy (Krebiehl et 726 
al., 2010). On the other hand, enhanced levels of autophagy have been linked to neuron loss in 727 
amyotrophic lateral sclerosis (Chen et al., 2012; Sasaki et al., 2011), marking it as a possible driver of 728 
neurodegeneration in this case. Such controversial findings may result from the complex roles 729 
autophagy plays in cellular homeostasis, stress resistance and also in programmed cell death (Tung et 730 
al., 2012; White and DiPaola, 2009), calling for further research to clarify its contribution to different 731 
types of neurodegeneration. In this regard, the dog could serve as a model more closely related to 732 
human physiology than rodents. Some canine hereditary diseases have already been linked to 733 
mutations in autophagy genes and many of these diseases have human homologs. For example, a 734 
polymorphism in the Ras-Related Protein Rab-24 (RAB24) gene, a member of the RAS oncogene 735 
family, which encodes a protein necessary for autophagosome trafficking, was found responsible for 736 
juvenile onset ataxia in some breeds (Agler et al., 2014). A missense mutation in the autophagy 737 
related 4D cysteine peptidase (ATG4D) gene was linked to vacuolar storage deficiency and 738 
neurodegeneration in Lagotto Romagnolo dogs (Kyöstilä et al., 2015). A study investigating juvenile 739 
onset neuroaxonal dystrophy in Spanish Water Dogs identified a non-synonymous mutation in the 740 
tectonin beta-propeller repeat containing 2 (TECPR2) gene, which had been linked to autophagosome 741 
formation (Hahn et al., 2015). A very similar type of neuroaxonal dystrophy exists in humans, hence 742 
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this finding could have actually suggested a possible genetic background to look for in affected 743 
people.  744 
Degenerative myelopathy (DM) is another example of a naturally occurring neurodegenerative 745 
disease in dogs, and shows a high degree of similarity to human amyotrophic lateral sclerosis (ALS). 746 
Both DM and ALS have been linked to mutations in the ROS neutralizing SOD1 gene, suggesting a 747 
shared genetic and metabolic background. Importantly, the possible contribution of autophagy to 748 
motor neuron loss was reported to be controversial both in DM (Ogawa et al., 2015) and in ALS 749 
(Chen et al., 2012). Autophagy also has a similarly controversial role in muscular atrophy in humans 750 
and dogs (Pagano et al., 2015; Sandri, 2010). Altogether, these findings indicate many homologies 751 
between dogs and humans regarding the regulation of autophagy in aging and disease.  752 
 753 
Deregulation of nutrient sensing 754 
 755 
Cellular metabolism, protein synthesis and autophagy are strictly regulated by various signaling 756 
pathways (Fig. 6) (He and Klionsky, 2009; Martindale and Holbrook, 2002). Most of these have 757 
evolved to synchronize cell growth and metabolism with nutrient availability; hence they are often 758 
referred to as nutrient sensing pathways. Many of them converge on the target of rapamycin (TOR) 759 
kinase (Fig. 6/A), a main factor in determining rates of protein turnover and metabolism 760 
(Wullschleger et al., 2006). In mammals, the TOR kinase may function in different complexes, named 761 
mTORC1 or mTORC2, depending on its protein partners. The mTORC1 complex, which includes the 762 
regulatory associated protein of MTOR (RPTOR) protein, corresponds to the invertebrate TOR 763 
complex in its regulatory interactions, while mTORC2 controls other intracellular processes. Knock-764 
down of TOR expression by RNA interference was shown to increase lifespan of C. elegans by 3-fold 765 
(Vellai et al., 2003). Later, similar effects of inhibiting TOR or its homologs were reported in S. 766 
cerevisiae (Kaeberlein et al., 2005), D. melanogaster (Kapahi et al., 2004) and laboratory mice (Wu et 767 
al., 2013), emphasizing its conserved role in the aging process (Kapahi et al., 2010).  768 
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Importantly, the function of mTOR can be efficiently inhibited by rapamycin, which is an already 769 
approved immunosuppressant in human medicine, and therefore has been proposed as a promising 770 
anti-aging compound to be used in humans. However, it was reported to cause severe side-effects in 771 
medical dosages (Hartford and Ratain, 2007). Therefore, optimal dosages, which do not cause 772 
undesirable syndromes, yet still exert longevity promoting effects should be carefully determined in 773 
pre-clinical studies. Actually, pharmaceutical studies have already been initiated to investigate the 774 
effects of rapamycin on the lifespan of dogs (Kaeberlein et al., 2016; Urfer et al., 2017).  775 
One of the main signaling pathways that regulate TOR activity is the insulin and IGF1 signaling (IIS) 776 
pathway (Fig. 6/B). It was first linked to aging when strains of C. elegans with doubled lifespan 777 
revealed a mutation in daf-2, the worm homologue of the IGF1 receptor (IGF1R) gene (Kenyon et al., 778 
1993). Later, a three-fold elongation in the non-replicative lifespan of S. cerevisiae was also linked to 779 
two genes that functioned in the glucose sensing pathway (Thevelein and de Winde, 1999). In flies 780 
and mice with hypomorphic alleles of IGF1R homologs, a significant increase in lifespan was 781 
observed together with characteristic pleiotropic effects (Holzenberger et al., 2003; Tatar et al., 2001). 782 
However, the longevity effect was less pronounced in mice, pointing at the possibility that the relative 783 
contribution of IIS to aging regulation may differ in various taxa.  784 
Importantly, comparisons between centenarian and younger human cohorts also showed associations 785 
between expected lifespan and serum IGF1 levels or genetic polymorphisms in related genes (Barbieri 786 
et al., 2003; Van Heemst et al., 2005). Furthermore, functional variants in IGF1R were shown to be 787 
enriched in centenarians (Suh et al., 2008). Polymorphisms in other genes of the IIS pathway were 788 
also linked to longevity in GWAS studies, although not without contradictions (Soerensen et al., 789 
2012a). In fact, some studies reported a decrease in GH and IGF1 plasma levels during normal aging 790 
(Breese et al., 1991; Sonntag et al., 1997). In this regard, it was hypothesized that the reduction in 791 
IGF1 levels may actually serve as a first line compensatory mechanism when age-related damage 792 
starts to accumulate in cells (López-Otín et al., 2013; Schumacher et al., 2008). Although low basic 793 
IIS signaling may delay aging, the overcompensation resulting from continuously accumulating 794 
damage in aged individuals may lead to insufficiencies in IGF1 signaling and this can cause further 795 
decline. This effect may be particularly relevant in the case of neural aging, because the brain has 796 
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special metabolic properties and a high need for optimal glucose levels. In support of this hypothesis, 797 
some age-related neurodegenerative states were linked to low IGF1 levels (Moloney et al., 2010; 798 
Sonntag et al., 2000, 2005). In addition, lower plasma IGF1 levels were shown to impair vascular 799 
maintenance in the brain (Sonntag et al., 1997). In this regard, dogs, which are more similar to 800 
humans in brain physiology and function than rodents, also seem promising to further unfold the 801 
relationship between IGF1 signaling and healthy aging.  802 
Importantly, functional mutations in the IGF1 and IGF1R genes have already been linked to body size 803 
variability in dogs (Hoopes et al., 2012; Rimbault et al., 2013; Sutter et al., 2007), similarly to humans 804 
and laboratory animals (Ishida et al., 1998; Liu et al., 1993; Perry and Dominy, 2009). The notion that 805 
small dog breeds usually live longer than large breeds (Galis et al., 2007; Greer et al., 2007; Kraus et 806 
al., 2013) also hints at the potential role of the IIS pathway in canine lifespan determination. In fact, 807 
the genomic region harboring the IGF1 locus were linked to size and lifespan across different breeds 808 
(Jones et al., 2008) and serum IGF1 levels were shown to correlate with age and obesity (Greer et al., 809 
2011) in individual dogs.  810 
Some other pathways linked to body size in dogs (Rimbault et al., 2013; Schoenebeck and Ostrander, 811 
2014) are also known to regulate TOR and autophagy. The SMAD family member 2 (SMAD2) gene, 812 
which functions in the transforming growth factor beta (TGF-β) pathway (Fig. 6/C) (Vellai, 2009) 813 
was associated with body size (Rimbault et al., 2013) and was previously found to be in linkage with 814 
mortality of dog breeds (Jones et al, 2008). The growth hormone receptor (GHR) and growth 815 
hormone (GH) genes, which also modulate dogs’ body size, were shown to affect longevity in humans 816 
(Soerensen et al., 2012a; van der Spoel et al., 2016), and in mice (Amador-Noguez et al., 2004; Bartke 817 
et al., 2001; Flurkey et al., 2001; Kinney et al., 2001).  818 
Both IIS and TGF-β signaling have several targets beyond TOR, and many of them were implicated in 819 
aging. For example, the forkhead box O (FOXO) transcription factors are targeted by both IGF1 and 820 
TGF-β signaling (Fig. 6/D), and were shown to have an important role in tumor suppression (Greer 821 
and Brunet, 2005) and age-related diseases (Hesp et al., 2015). The worm homologue of the 822 
mammalian FOXO genes, daf-16 was one of the first genes linked to extreme longevity in C. elegans, 823 
as it was found necessary for the longevity effect observed in daf-2 deficient worms (Kenyon et al., 824 
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1993; Larsen et al., 1995; Lin et al., 1997; Ruvkun et al., 1997). Out of the four mammalian 825 
orthologues, FOXO3a has been associated with aging in human cohort studies (Anselmi et al., 2009; 826 
Soerensen et al., 2010; Willcox et al., 2008). FOXO1a SNPs were also reported to affect longevity, 827 
however in a gender specific manner (Li et al., 2009). In addition, FOXO3 was shown to regulate 828 
autophagy in skeletal muscle, and play a role muscular atrophy (Mammucari et al., 2007). Despite the 829 
emphasized role of FOXOs in disease and aging, the canine homologues have not yet been studied in 830 
detail.  831 
Sirtuins (Fig. 6/E) and the 5' AMP-activated protein kinase (AMPK) also play an important role in 832 
nutrient sensing. Sirtuins function as nicotinamide adenine dinucleotide (NAD) dependent protein 833 
deacetylases, sensing the levels of NAD in cells. Decreased NAD levels were shown to reduce their 834 
activity and thus NAD replacement therapies have been suggested as possible anti-aging interventions 835 
(Chini et al., 2017). AMPK detects the levels of adenosine monophosphate (AMP) in cells and it is 836 
able to counteract IGF1 signaling by inhibiting TOR (Gwinn et al., 2008; Inoki et al., 2003) and 837 
activating FOXO3a (Sanchez et al., 2012). It was also suggested to play a major neuroprotective role 838 
by activating the UNC-51 Like 1 (ULK1) kinase (Kim et al., 2011), a key autophagy inducing protein 839 
(Wong et al., 2013).  840 
Both sitruins and AMPK are targets of several proposed anti-aging drugs. For example, the anti-841 
diabetic drugs, metformin and acarbose were both shown to exert an anti-aging effect in model 842 
animals (Anisimov et al., 2011; Cabreiro et al., 2013; Harrison et al., 2014; Martin-Montalvo et al., 843 
2013), and to modulate various aging-related intracellular processes, including the activation of 844 
AMPK (Chan et al., 2016; Cho et al., 2015; Lu et al., 2015). Importantly, metformin was actually 845 
reported to decrease mortality of diabetic people in comparison to patients treated with other drugs in 846 
a retrospective large-scale study (Bannister et al., 2014). Consequently, metformin has been suggested 847 
as a promising candidate for anti-aging interventions (Barzilai et al., 2016). It may also be easily 848 
applied in family dogs to test its longevity enhancing potential, because it was already shown to have 849 
relatively mild side effects in dogs (Heller, 2007).  850 
However, it is important to note that all of these drugs, including rapamycin, may exert pleiotropic 851 
effects in organisms through various cellular signaling and regulatory mechanisms. For example, 852 
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metformin was implicated to modify the composition of the gut microbiome in diabetic patients 853 
(Forslund et al., 2015), which in turn can indirectly affect aging and neural function (see below in the 854 
section “Microbiome”). Such pleiotropic effects should be thoroughly considered in humans and 855 
family dogs, as both are exposed to variable environmental stimuli, have diverse genetic background 856 
and may use other medications, which can alter the mechanisms of actions of anti-aging compounds 857 
through complex interactions. 858 
A fairly recently emerged possible regulator of aging that interacts with IGF1 signaling and FOXO 859 
activity is the klotho hormone, which was first identified in mice as a longevity factor (Kuro-o et al., 860 
1997; Kurosu et al., 2005). The klotho (KL) gene represents an example of longevity genes that are 861 
missing from invertebrate models, but show functional polymorphisms associated with human 862 
longevity (Arking et al., 2002).  863 
 864 
Mitochondrial dysfunction 865 
 866 
Nutrient sensing pathways converge on the regulation of mitochondrial activity, as these organelles 867 
are the main sources of energy (in the form of adenosine-triphosphate, ATP) in eukaryotic cells under 868 
normal circumstances, when enough oxygen is present. The availability of nutrients determines the 869 
rate of mitochondrial respiration, which, however, generates not only ATP, but chemical by-products, 870 
including reactive oxygen species (Fig. 7/A). The oxidative burden created by mitochondria may be 871 
especially high in neurons, which solely depend on aerobic mitochondrial respiration as energy 872 
source. In accordance with this, associations between chronological age and a higher ROS production 873 
rate of mitochondria in brain cells were demonstrated in rodents (Navarro and Boveris, 2004; 874 
Petrosillo et al., 2008), humans (Mecocci et al., 1993) and also in dogs (Head et al., 2009). Oxidative 875 
DNA lesions could also occur in the mitochondrial genome, and consequently modify gene 876 
expression and optimal function of mitochondria, possibly leading to a positive feedback mechanism 877 
in the generation of extensive levels of ROS. In fact, age-related changes in mitochondrial gene 878 
expression profiles were reported in mice (Manczak et al., 2005) and the accumulation of 879 
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mitochondrial DNA mutations, mainly deletions, in certain brain regions was linked to impaired 880 
mitochondrial respiration in humans (Corral-Debrinski et al., 1992; Kraytsberg et al., 2006). 881 
Importantly, mitochondrial dysfunction is considered to be a main driver of the pathophysiology of 882 
neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease and amyotrophic 883 
lateral sclerosis (Lin and Beal, 2006). For example, gain-of-function mutations in the Leucine-rich 884 
repeat kinase 2 (LRRK2) gene causing autosomal dominant form of PD (Di Fonzo et al., 2005) were 885 
shown to result in hampered mitochondrial function (Mortiboys et al., 2010). Although the generation 886 
of malfunctioning mitochondria may be counterbalanced by elevated levels of mitophagy, a form of 887 
macroautophagy that is able to degrade mitochondria, it is not yet clear in the literature how 888 
mitophagic activity is generally changed in affected cells of PD patients (Chu, 2018).  889 
The role of mitochondrial dysfunction and increased oxidative burden in neural aging was also 890 
investigated in dogs. In general, dog brains were shown to accumulate oxidative damage with age (for 891 
more details, see Section “Genomic instability in aging dogs”). In a study published by Head et al. in 892 
2009, mitochondrial ROS production and complex I driven respiration rate showed significant 893 
alterations between old and young laboratory Beagle dogs from the same colony, with aged dogs 894 
having higher ROS production and lower respiration rate. The same study reported that a diet 895 
enriched with antioxidants and mitochondrial cofactors improved mitochondrial respiration rate and 896 
reduced ROS production in aged dogs, and also had a positive effect on their cognitive performance. 897 
In another study, a ketosis inducing diet was shown to modify mitochondrial function and, to some 898 
extent, reduce amyloid-β deposition in dog brains (Studzinski et al., 2008). Interestingly, Christie et 899 
al. reported in 2009 that short term supplementation with lipoic acid (LA), which is both an important 900 
mitochondrial cofactor and a powerful antioxidant, did not improve cognitive function of aged Beagle 901 
dogs, contrary to their previous findings where LA had been used together with other antioxidants 902 
(Cotman et al., 2002; Milgram et al., 2002a, 2002b). Furthermore, another mitochondrial cofactor, 903 
acetyl-L-carnitine (ALCAR), when supplemented in itself, was shown to decrease cognitive 904 
performance (Christie et al., 2009). In a 2016 paper, Snigdha et al., who also failed to replicate 905 
findings about the beneficial effects of antioxidant enriched diet on the cognition of aged Beagle dogs, 906 
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suggested that these controversies could have resulted from differences in the baseline nutrition of 907 
dogs.  908 
Nevertheless, such findings could also result from a more complicated interaction between ROS and 909 
aging, as it was suggested by several authors, who re-evaluated the classical theories about the 910 
connection between mitochondria, ROS and general longevity, based on the increasing body of 911 
experimental evidences (Hekimi et al., 2011; López-Otín et al., 2013). Accordingly, the ambiguous 912 
results listed above could result from altered mitochondrial homeostasis (mithormesis) in cells and not 913 
solely from impaired mitochondrial respiration and ROS overproduction. The concept of mithormesis 914 
suggests that mild mitochondrial stressors may actually benefit cellular health and longevity (López-915 
Otín et al., 2013). Such minor stress, which, for example, can be induced by pharmaceutical agents, 916 
can boost mitochondrial turnover and activate defensive mechanisms (Haigis and Yankner, 2010). As 917 
it was shown that malfunctioning mitochondria can also directly affect aging by other mechanisms 918 
than increased oxidative stress (Edgar et al., 2009; Hiona et al., 2010; Trifunovic et al., 2004; 919 
Vermulst et al., 2008), for example by inducing apoptosis (Kroemer et al., 2007) (Fig 7/B), elevated 920 
mitochondrial turnover can actually protect cells from these deleterious effects. Since both resveratrol 921 
and metformin have been hypothesized to be mild mitochondrial toxins, they may also exert their 922 
anti-aging effect at least partly by inducing mithormesis (López-Otín et al., 2013). 923 
Altogether, mitochondria-targeting interventions may require mindful considerations, especially in 924 
populations with high genetic variability. Genetic variants in mitochondrial genomes are known to 925 
cause disorders in humans (Koopman et al., 2012), and they may also substantially alter the capability 926 
of cells to cope with mitochondrial poisons (Finsterer and Frank, 2016). This means that interactions 927 
between mitochondrial genotypes and specific chemical compounds should also be considered in anti-928 
aging intervention studies. In this regard, dogs can again become ideal models with good 929 
translatability. Several mitochondrial diseases are known in dogs, which have human homologs, such 930 
as the sensory ataxic neuropathy found in Golden Retriever dogs (Baranowska et al., 2009) or the 931 
familial dilated cardiomyopathy in Doberman Pinschers (Meurs et al., 2012). As several promising 932 
anti-aging drugs are likely to be tested in dogs in pre-clinical studies, looking into their effects on 933 
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mitochondrial function and testing their possible interactions with mitochondrial genotypes can be 934 
highly relevant for humans.  935 
 936 
Cellular senescence 937 
 938 
All the mechanisms discussed so far act congruently to modulate cellular metabolism, growth, 939 
proliferation and, eventually, senescence, which is characterized by a permanent cell cycle arrest and 940 
stereotyped phenotypic changes (Campisi and d’Adda di Fagagna, 2007; Collado et al., 2007). 941 
Specific mechanisms serve as effectors of senescence in response to unrepaired DNA damage, 942 
mitochondrial malfunction and other forms of excessive stress. Most famously, telomere attrition 943 
represents a somewhat genetically programmed route to cellular senescence as it was implied from 944 
experiments with human fribroblasts (Allsopp et al., 1992; Harley et al., 1990). However, the fact that 945 
cultured murine cells also reached senescence despite their telomerase positivity, suggested that other 946 
mechanisms, like increased oxidative damage in cultured conditions, should have contributed to their 947 
limited proliferative potential (Sherr and DePinho, 2000).  948 
Among other examples, the activation of the p16INK4a/Rb and the p14ARF/p53 signaling pathways are 949 
both able to induce cellular senescence in response to time-dependent changes, including the 950 
accumulation of DNA damage (d’Adda di Fagagna, 2008). The expression of the INK4/ARF locus, 951 
which encodes the p16INK4, p15INK4 and p14ARF proteins in humans, was reported to correlate with 952 
chronological age in various tissues of rodents and humans (Krishnamurthy et al., 2004, 2006; Liu et 953 
al., 2009b; Ressler et al., 2006), nominating it as an ideal biomarker of aging. Importantly, the 954 
INK4/ARF locus can directly affect healthspan and longevity, as it was shown experimentally in mice 955 
(Matheu et al., 2009). Furthermore, simultaneous overexpression of INK4/ARF and p53 caused 956 
extended lifespan in mice, accompanied by cancer resistance and reduced neural decline (Carrasco-957 
Garcia et al., 2015; Matheu et al., 2007). The human INK4/ARF locus was also found to be the most 958 
strongly associated locus with several age-related pathologies in a meta-analysis of GWAS studies 959 
(Jeck et al., 2012), and it was associated with longevity in a smaller cohort study (Emanuele et al., 960 
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2010). Interestingly, the elevated expression and activity of p53 in itself did not increase longevity in 961 
experimental studies (García-Cao et al., 2002; Mendrysa et al., 2006). Actually, certain hyperactive 962 
variants of p53 were shown to reduce lifespan in mice, although with simultaneously prompting 963 
increased cancer resistance (Dumble et al., 2007; Tyner et al., 2002).  964 
In this regard, it is important to note that the p14/p53 pathway, together with p16/pRb, are 965 
fundamental tumor suppressor mechanisms, therefore, they unquestionably contribute to healthy 966 
aging by forcing potentially malignant cells into a senescent state or into programmed cell death 967 
(Hickman et al., 2002).  968 
This anti-tumor effect of induced cellular senescence can explain the contradictory findings regarding 969 
the role of p53 and other tumor suppressor mechanisms in aging (Rodier and Campisi, 2011), as a 970 
possible trade-off exists between longevity and cancer-occurrence (Matheu et al., 2008). 971 
So far, no studies have investigated the canine homologs of the INK4/ARF locus and p53 in relation to 972 
aging. However, and not surprisingly, their role and regulation in tumorigenesis showed high 973 
similarities between dogs and humans (Lutful Kabir et al., 2013; Rowell et al., 2011), suggesting that 974 
their roles in aging, especially in healthy aging, are also conserved in dogs.  975 
 976 
Accumulation of senescent cells in tissues 977 
 978 
The time-dependent upregulation of senescence inducing mechanisms means that the ratio of aged 979 
cells may gradually increase in the tissues of older individuals. Indeed, a marked elevation of 980 
senescent cell numbers was reported in old mice (Wang et al., 2009), although not in all tissues. 981 
Importantly, this accumulation process can result from both the increased generation of senescent 982 
cells and a decreased activity of macrophages that are able to eliminate aged or apoptotic cells from 983 
tissues. As the activity of the innate immune system was shown to decrease with age (Mahbub et al., 984 
2011; Plowden et al., 2004), it is likely that reduced phagocytic capacity also contributes to 985 
organismal aging through the disrupted elimination of senescent cells (López-Otín et al., 2013). 986 
Furthermore, senescent cells were shown to produce inflammatory signals and create a special 987 
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inflammatory microenvironment around themselves (Kuilman et al., 2010; Rodier and Campisi, 988 
2011), which may directly contribute to tissue aging by creating a positive feedback loop and 989 
inducing cellular senescence in neighboring cells (Nelson et al., 2012). This so-called “bystander” 990 
effect was actually shown to modulate the number of senescent cells in vivo in mice (da Silva et al., 991 
2018). 992 
Little is known about the accumulation of senescent cells in canine tissues, although this phenomenon 993 
is also likely to show fundamental similarities with other mammalian species. As there is a growing 994 
interest toward pharmacological approaches to deplete senescent cells in tissues by specific apoptosis 995 
inducing agents (senolytic drugs) (Kirkland et al., 2017) dogs may eventually be involved in testing 996 
these types of anti-aging interventions.  997 
 998 
Stem cell exhaustion 999 
 1000 
Tissue renewal depends on the abundance and replicative capacity of tissue specific stem cells, which 1001 
can replace cells lost by terminal senescence or apoptosis. Thus, the age-related increase in cellular 1002 
senescence may also result in elevated stem cell activation and differentiation, eventually causing the 1003 
depletion of stem cell pools. In fact, early exhaustion of stem cells in certain tissues was shown to 1004 
accelerate aging in flies and mice (Cheng et al., 2000; Kippin et al., 2005; Rera et al., 2011). 1005 
Furthermore, it was shown that increased basic fibroblast growth factor (FGF2) signaling in muscle 1006 
tissues of aged mice accelerated depletion of stem cells by forcing them to leave quiescent state 1007 
(Chakkalakal et al., 2012).  1008 
Importantly, senescence may also directly affect stem cells, depriving them from the ability to 1009 
replicate and differentiate even if they are still present in tissues. For example, hematopoietic stem 1010 
cells (HSC) were reported to have reduced replicative capacity in both aged mice and humans, mainly 1011 
because of accumulating DNA damage (de Haan and Lazare, 2018). This reduction can explain the 1012 
old age anemia of elderly people (Patel, 2008). Importantly, similar forms of age-associated changes 1013 
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in blood parameters, including anemia, were reported in dogs (Radakovich et al., 2017; Strasser et al., 1014 
1993).  1015 
Stem cell quiescence and activation is regulated by many of the already discussed aging pathways, 1016 
including p53 and IIS (Liu et al., 2009a; Xian et al., 2012). Thus, pharmacological interventions that 1017 
act on these could also affect stem cell dynamics. In this regard, the inhibition of mTOR was shown to 1018 
have beneficial effects on aging by promoting cellular rejuvenation (Castilho et al., 2009; Chen et al., 1019 
2009; Yilmaz et al., 2012). Furthermore, pharmacological inhibitors of the Cell Division Cycle 42 1020 
(CDC42) protein, which is an inducer of HSC senescence, were shown to promote rejuvenation of 1021 
HSC pools in mice (Florian et al., 2012). 1022 
Besides pharmacological interventions, stem cell therapy has also been suggested as a possible anti-1023 
aging intervention, with highlighted promises to treat certain forms of neurodegeneration (Lindvall et 1024 
al., 2004; Trounson and DeWitt, 2016). In this regard, stem cell therapy trials conducted on dogs 1025 
affected with CCD or other forms of neurodegeneration could represent a crucial step before 1026 
progressing to human trials. In the case of the Golden Retriever model for Duchenne muscular 1027 
dystrophy, successful stem cell based interventions had actually preceded human clinical trials (Pelatti 1028 
et al., 2016). Other instances of dog stem cell therapy trials were discussed by Hoffman and Dow 1029 
(2016).  1030 
 1031 
Altered intercellular communication 1032 
 1033 
In the course of evolution, several mechanisms have evolved to establish efficient communication 1034 
between cells in multicellular organisms. Intercellular communication types include paracrine, 1035 
endocrine and neurocrine signaling and all of these can be involved in the aging process. Especially 1036 
hormones and other endocrine signal transducers can have a main role in systemic aging regulation. 1037 
Actually, GH and the insulin/IGF1 signaling pathway belong to these main systemic regulators, most 1038 
of which are supervised by the hypothalamic-pituitary-adrenal (HPA) and -thyroid axes. Endocrine 1039 
signaling also involves hormones synthetized by the digestive system and reproductive glands. 1040 
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Furthermore, small molecules produced by gut bacteria can also have systemic effects on the host 1041 
organism (Donia and Fischbach, 2015).  1042 
 1043 
Neuroendocrine signaling 1044 
 1045 
The central nervous system (CNS) mainly functions as conductor, coordinating various processes of 1046 
the organism according to intrinsic and extrinsic stimuli. Signals provided by the CNS – together with 1047 
the digestive system – can affect every part of the body. In this regard, “neural aging” has recently 1048 
gained more focus as a central mechanism, which could impact the systemic aging of the whole 1049 
organism (Weir and Mair, 2016). In support of this theory, both neuronal and intestinal genetic 1050 
manipulations, which reduced mitochondrial electron transport chain function, were shown to extend 1051 
lifespan in C. elegans, while similar manipulations in other tissues had no longevity effect (Durieux et 1052 
al., 2011). 1053 
Importantly, several signaling pathways have been hypothesized to play fundamental roles in both 1054 
neural senescence and systemic aging. For example, IGF1, together with the brain derived 1055 
neurotrophic factor (BDNF) and serotonin were shown to affect brain aging, and modulate metabolic 1056 
changes linked to caloric restriction across the body (Mattson et al., 2004). The hypothalamus also has 1057 
major implications in aging. For example, reproductive aging was shown to be controlled by the 1058 
gonadotropin releasing hormone (GnRH), which is produced by special cells in the hypothalamus 1059 
(Yin and Gore, 2006). Age-related reduction in GnRH levels, in response to activation of 1060 
inflammatory pathways, was suggested to aggravate frailty and neurodegeneration in the elderly 1061 
(Zhang et al., 2013). Altogether, age-related changes in the hypothalamus and, consequently, in HPA 1062 
regulation seem to play a central role in the systemic regulation of aging (Deuschle et al., 1997; Kim 1063 
and Choe, 2019). The activity of the hypothalamus and the HPA axis was reported to show similar 1064 
general attributes in dogs as in humans and age-related changes in the HPA axis were already 1065 
assessed in dogs (Reul et al., 1991; Rothuizen et al., 1991). However, further studies will be needed to 1066 
investigate the function of GnRH and other hormones in canine aging.  1067 
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 1068 
Parabiosis experiments and systemic factors of aging 1069 
 1070 
Most molecular effectors of systemic aging are excreted into the blood, by which they can reach every 1071 
part of the body. This mediatory function of the blood was proven by parabiosis experiments in 1072 
rodents, when the artificial connection of the circulatory systems of old and young animals resulted in 1073 
beneficial effects on the cognitive performance of aged individuals (Katsimpardi et al., 2014; Villeda 1074 
et al., 2014). Several of the possible effector molecules behind this phenomenon have been revealed 1075 
since (Demontis et al., 2014; Elabd et al., 2014; Loffredo et al., 2013). Interestingly, some of the 1076 
systemic factors present in human umbilical cord plasma were shown to beneficially influence brain 1077 
aging when applied experimentally in mice (Castellano et al., 2017), indicating conserved functions 1078 
for these molecules. It is important to note, however, that other blood-borne factors were shown to 1079 
actually promote aging. For example, the β2 microglobulin was reported to negatively affect cognitive 1080 
performance and regenerative potentials in aged mice (Smith et al., 2015). Although parabiosis is not 1081 
really applicable in humans and in family dogs, the identified systemic factors seem promising as 1082 
effectors or targets for anti-aging interventions in both species and may be introduced to pre-clinical 1083 
studies conducted on dogs. 1084 
 1085 
Extracellular vesicles 1086 
 1087 
In addition to hormones and metabolites, extracellular vesicles released by cells into the blood, called 1088 
exosomes and ectosomes, have emerged as important transducers of various cellular signals 1089 
(Meldolesi, 2018) and their content, including miRNAs, may provide diagnostic and prognostic 1090 
measures for many diseases, including AD (Cheng et al., 2014, 2015; Thind and Wilson, 2016; Van 1091 
Giau and An, 2016). Consequently, exosomes may also modulate aging and neurodegeneration 1092 
(Cheng et al., 2015). In support of this, it was recently demonstrated by Zhang et al. (2017) that the 1093 
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stem cells of the hypothalamus could affect the speed of aging by exosomal miRNAs secreted into the 1094 
cerebrospinal fluid in mice.  1095 
Exosome research in dogs have been limited until recently. However, blood miRNA levels – which 1096 
were hypothesized to be mainly found in exosomes – were reported to correlate with disease 1097 
phenotypes in canine Duchenne muscular dystrophy (Mizuno et al., 2011). Similarly, miRNA content 1098 
in circulating exosomes was shown to correlate with progression of secondary heart failure in cases of 1099 
myxomatous mitral valve disease in dogs (Yang et al., 2017). Direct links were suggested between 1100 
alterations in urinary exosome formation, miRNA content and occurrence of kidney disease in dogs 1101 
by Ichii et al. in 2017. Furthermore, a recent study reported exosome derived miRNAs as biomarkers 1102 
for canine mammary tumors (Fish et al., 2018). Altogether, investigations about the connections 1103 
between exosome content and aging or age-related pathologies in dogs may lead to the identification 1104 
of diagnostic markers with potential translational prospects into human studies.  1105 
 1106 
Immunaging and inflamm-aging 1107 
 1108 
Together with the CNS, the immune system has a main systemic regulatory function in the organism. 1109 
Most immune cells synthesize various signaling molecules that act either in a paracrine or endocrine 1110 
manner and can also provide defense against various pathogens. Macrophages, which are part of the 1111 
innate immune system, can wander throughout the body and have important roles in tissue 1112 
homeostasis by cleaning cellular debris and pathogens.  1113 
The human immune system is known to experience a general age-related decline in its function and in 1114 
the abundance of some cell types, although the exact details of reported changes may vary between 1115 
studies (Pawelec, 2018). In general, reduced numbers of naïve CD8+ T cells and moderately elevated 1116 
numbers of memory T cells were found to be linked to aging. Importantly, bone marrow derived 1117 
macrophages were also shown to lose phagocytic capacity with aging (Kim et al., 2017; Li et al., 1118 
2017), which can contribute to the accumulation of senescent cells in tissues. 1119 
In addition, it has long been hypothesized that systemic age-related changes in certain immune 1120 
components linked to inflammation will lead to a so-called inflamm-aging phenomenon. Importantly, 1121 
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the exact interactions between immunosenescence and inflamm-aging have not yet been clarified 1122 
(Fulop et al., 2018), hence further studies using systems biology approaches may shed light on the 1123 
detailed mechanisms that underlie them (Ostan et al., 2017). 1124 
Both immunosenescence and inflamm-aging were proposed as contributors to aging and age-related 1125 
pathologies in dogs (Day, 2010). Large scale hematologic and serum phenotyping studies done in 1126 
various breeds (Chang et al., 2016; Faldyna et al., 2001; Lawrence et al., 2013) showed that several of 1127 
the assessed blood parameters correlated with chronological age. Regarding the immune system, T 1128 
and B lymphocytes were mainly affected in most cases, however the directions of these changes were 1129 
contradictory (Faldyna et al., 2001; Greeley et al., 2006; HogenEsch et al., 2004; Massimino et al., 1130 
2003; Reis et al., 2005). However, a recent study reported that changes in naïve and memory T cell 1131 
numbers in old dogs were similar to those previously described in most human studies (Withers et al., 1132 
2018). Importantly, it was shown that lifelong calorie restriction positively affected lymphocyte 1133 
numbers in aged dogs (Greeley et al., 2006). Taken together, the dog may become one of the most 1134 
applicable model animals to study immunosenescence and inflamm-aging, and to test interventions 1135 
that could attenuate the deterioration of the immune system.  1136 
 1137 
Microbiome 1138 
 1139 
Recent findings suggest, that both systemic metabolism and immune function can be modulated by 1140 
bacteria inhabiting the gut, termed gut microbiome (Tremaroli and Bäckhed, 2012). The microbiome 1141 
can interact with the host organism through various chemical signals, and some of these may directly 1142 
affect the function of distant organs, like the brain (Sharon et al., 2016). Therefore, the microbiome 1143 
may fundamentally affect health and disease, and possibly aging (Zapata and Quagliarello, 2015). 1144 
This was supported by findings that reported consistent changes in the composition of the microbiome 1145 
in elderly people and centenarians (Biagi et al., 2010, 2017). Although these correlations do not 1146 
necessarily indicate causative links (Saraswati and Sitaraman, 2015), the theory of microbial 1147 
modulation of aging has been gaining more and more scientific interest. Importantly, experimental 1148 
evidences from rodents have already shown that the microbiome can affect the progression of 1149 
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neurodegeneration (Sampson et al., 2016). Furthermore, probiotics and prebiotics, which can 1150 
beneficially alter the composition of the microbiome, were reported to positively influence the aging 1151 
of the gut and systemic inflammation in people (Patel et al., 2014; Vaiserman et al., 2017). 1152 
Currently, not much is known about age-related changes in the canine gut microbiome, however there 1153 
is growing research interest in this field. Future findings may have direct implications to humans as 1154 
well, because the composition of the canine microbiome was shown to be more similar to humans 1155 
than that of mice and pigs (Coelho et al., 2018) and actual correlations between the microbiomes of 1156 
dogs and people living in the same household were also reported (Misic et al., 2015). Because dogs 1157 
age faster than humans, they can be ideal models to test the potential aging effects of prebiotics and 1158 
probiotics in longitudinal follow-up studies. Importantly, some probiotics used in humans were 1159 
already suggested to promote health in dogs (Grześkowiak et al., 2015), and this can facilitate their 1160 
adaptation for systemic anti-aging intervention trials.  1161 
It is important to note, that other microbial niches on the human body may also affect aging and 1162 
disease, as it was implicated when oral microbiota and inflammation were linked to the progression of 1163 
Alzheimer’s disease (Pritchard et al., 2017). As periodontitis is also a serious health issue in aged 1164 
dogs (Albuquerque et al., 2012), this link between oral microbiome and neurodegeneration 1165 
undoubtedly requires further focus in canine aging research and veterinary medicine and may also 1166 
benefit humans by translational studies (An et al., 2018).  1167 
 1168 
 1169 
Conclusions and perspectives 1170 
 1171 
Considering the remarkably complex nature of biological processes that underlie aging, it is not 1172 
surprising that finding a biological model for aging that would unify all relevant aspects is 1173 
challenging. Family dogs have been proposed as ideal models to complement findings from other 1174 
model organisms (Fig. 8), however the still limited knowledge about the exact genetic and regulatory 1175 
mechanisms that underlie their aging may restrict their applicability in translational studies. Although 1176 
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searching for links between genetic variants and aging phenotypes would be more challenging than in 1177 
the case of other phenotypic parameters, which are easier to measure, such approaches seem 1178 
indispensable to gain insight into the main genetic mechanisms that modulate aging variability in 1179 
dogs. Actually, there has been some efforts along these lines (Jones et al., 2008), however interbreed 1180 
comparisons have a limited potential to reveal the exact variants responsible for longevity differences 1181 
between individuals. Future studies should aim at intrabreed approaches, for which both genetic and 1182 
aging related data should be available from the same animals. Furthermore, gene expression mapping 1183 
could be a novel approach to pinpoint at pathways that show changes between young and old dogs or 1184 
between dogs with short and long lifespan. Although it could be challenging to obtain good quality 1185 
tissues from a large number of family dogs with known lifespan and other parameters, biobanks 1186 
created following human examples may help to overcome this limitation in the long term.  1187 
As recent findings have increased the palette of possible anti-aging interventions, making almost all of 1188 
the nine hallmarks of aging (López-Otín et al., 2013) targetable by drugs, a growing interest for pre-1189 
clinical testing of these compounds is expected. Consequently, the dog may gain more and more 1190 
attention as a pre-clinical model species. Because family dogs are exposed to almost the same 1191 
background effects, which can modify the outcome of interventions, as are people, they might even 1192 
become inevitable to provide a suitable model to assess the effects of anti-aging interventions on 1193 
natural populations.  1194 
It is important to emphasize that characterizing the aging process of dogs and establishing effective 1195 
interventions within the species may benefit humans not only by clarifying scientific questions, but 1196 
also by making it possible to increase the healthy lifespan of companion and service animals. Owning 1197 
a guide dog or service dog can lead to great improvements in the quality of life of disabled people. 1198 
Also, service dogs may facilitate human-human interactions and contribute to the socio-emotional 1199 
well-being of their owners. Caron-Lormier et al. (2016) reported that most guide dogs were retired 1200 
due to age related diseases or simply old age, after an average of 8.5 years of service. Increasing the 1201 
lifespan and healthspan of working dogs could be emotionally beneficial for their owners, and also 1202 
could be financially advantageous for societies, as the training of these animals is time consuming and 1203 
expensive. Furthermore, providing average family dogs an elongated health span may also benefit 1204 
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their owners. Several studies have reported a positive correlation between dog walking, physical 1205 
activity and health variables in owners, although results were often controversial, suggesting the need 1206 
for further research on this topic (Brown and Rhodes, 2006; Christian et al., 2016; Lentino et al., 1207 
2012). In some cases, improvements were most pronounced in older cohorts (Curl et al., 2016; Garcia 1208 
et al., 2015; Thorpe et al., 2006; Toohey et al., 2013). Experiences from animal assisted therapy also 1209 
suggested that animal-human interactions may help the elderly to experience a successful aging 1210 
course (Baun and Johnson, 2010). Therefore, providing a long and healthy life for companion animals 1211 
may benefit the health and welfare of their owners as well. 1212 
Taken together, strong scientific evidence suggests that utilizing dogs as models of human aging and 1213 
anti-aging interventions may hold prospects unattainable by other model organisms, if the complex 1214 
interactions between genetics and environmental factors are taken into consideration. Thus canine 1215 
studies on aging may bring forward results that can eventually benefit the elderly as well as their pets. 1216 
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Figure 1. Main pathways of cellular senescence 2718 
The figure depicts eight categories of age determining pathways each of which involves several 2719 
gene products. (A) The DNA repair machinery provides the first line of defence against 2720 
mutagenic agents and also interacts with mobile DNA elements through repairing double strand 2721 
breaks induced by transposons. (B) Reactive oxygen species produced by mitochondrial 2722 
respiration represent an inner source for DNA lesions, thus interact with the DNA repair 2723 
machinery: proper functionality of DNA repair enzymes is required to protect cells from oxidative 2724 
damage, however elevation in the level of oxidative stress may overburden the repair machinery. 2725 
(C) Macroautophagy is a protective mechanism against malfunctioning mitochondria that might 2726 
cause oxidative stress, while together with other clearance mechanisms it also functions to remove 2727 
misfolded proteins and protein aggregates. It also functions as a mechanism for programmed cell 2728 
death (indicated with dashed line between autophagy and cell cycle control). (D) The activity of 2729 
the autophagy machinery is strictly regulated by different signaling pathways many of which 2730 
functions in metabolite sensing and cell growth control. (E) Cell cycle control is a main 2731 
determinant of cellular senescence. Also, on a multicellular level, dysregulation of cell cycle 2732 
control may decrease lifespan by initiating tumor formation. (F) In many species telomeres 2733 
function as a measuring mechanisms to limit the number of potential cell cycles. When telomere 2734 
length reaches a critical shortness, it will activate cell cycle control mechanisms to render the cell 2735 
into a senescent state. The telomerase enzyme was also shown to interact with global genomic 2736 
chromatin maintenance. (G) Epigenetic regulation involves two main mechanisms, the 2737 
methylation of CpG islands and modification of the chromatin structure through histone proteins. 2738 
Chromatin structure at telomeres is important for telomere maintenance and the repression of 2739 
retroelements by CpG methylation may prevent DNA damage caused by transposon mobilization. 2740 
(H) Derepression of mobile DNA elements, primarily of retroelements in mammalian genomes, 2741 
may result in an increased frequency of double strand breaks and insertion mutagenesis. 2742 
 2743 
 2744 
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Figure 2. The role of telomeres and epigenetics in chromosomal integrity and aging 2745 
The figure illustrates how shortening of telomeres and changes in the epigenetic pattern affect the 2746 
overall structure of chromosomes. (A) Chromosome ends are protected by repetitive sequences 2747 
called telomeres in most eukaryotic organisms. This telomere sequence, consisting of TTAGGG 2748 
repeats, shortens with each DNA replication, which eventually triggers cellular senescence. (B) 2749 
Chromatin changes occur on the first level of DNA packaging, when the DNA double strand is 2750 
coiled up on nucleosomes. Tight coiling on nucleosomes results in a heterochromatic state, when 2751 
the DNA double helix is not accessible to many proteins, including the transcription machinery. 2752 
In contrast, reduction in the number of nucleosomes lead to a less coiled and less dense state 2753 
rendering the DNA more open to transcription. (C) DNA methylation at CpG islands causes 2754 
chemical changes directly in the DNA double helix. Cytosine methylation is usually linked to 2755 
silencing of transcription. Methylation also interacts with chromatin structure: increased CpG 2756 
methylation is usually linked to heterochromatic state. (D) Changes in chromosomal structure 2757 
during aging is characterized by a decrease of heterochromatic regions (symbolized by darker 2758 
color) and an increase of euchromatic regions (symbolized by lighter colors). 2759 
 2760 
Figure 3. The protective roles of the DNA repair machinery 2761 
The DNA repair machinery counteracts the effects of variable DNA damaging processes. In 2762 
healthy cells the repair machinery can balance these deleterious effects (represented by red 2763 
arrows), however in the case of increased mutagenic burden (e.g. exposure to UV-radiation), or 2764 
when members of the repair machinery are not functioning properly, the balance can be lost and a 2765 
growing number of DNA lesions may cause the cells to die or turn malignant. (A) The function of 2766 
the Mismatch Repair system (MMR) is coupled to DNA replication where mismatching base-2767 
pairs can be formed spontaneously, and are being identified and repaired by MMR proteins. (B) 2768 
The Base Excision Repair (BER) system can detect damaged / chemically modified bases in the 2769 
DNA helix, and remove them, resulting in an apurinated site, which will induce endonucleases to 2770 
I r vi
ew
108 
 
cut back the DNA strand. The single strand break is repaired by a DNA polymerase based on the 2771 
sequence of the complementary strand and the newly synthesized sequence is ligated to the 2772 
original DNA strand by a ligase enzyme. (C) Mutations that disrupt the normal topology of the 2773 
DNA double helix, like the UV-light induced formation of pyrimidine dimers is corrected by the 2774 
Nucleotide Excision Repair (NER) system. This machinery recognizes aberrant DNA structure 2775 
caused by chemically modified nucleotides and removes these nucleotides resulting in a single 2776 
strand break, which will be filled in by DNA polymerase and ligase enzymes. (D-E) The most 2777 
destructive form of DNA damage is double strand break (DSB) which could trigger an immediate 2778 
apoptotic response if it fails to be repaired. Two distinct mechanisms are used by cells to repair 2779 
DSB, one is Homologous Recombination (HR) and the other is Non-Homologous End Joining 2780 
(NHEJ). HR is a fundamental process also linked to meiosis in eukaryotic cells, and it provides a 2781 
possibility to recover the damaged DNA strand in full length, by using a homologous DNA helix 2782 
(e.g. the sister chromatid) as template. In contrast, NHEJ may link ends of double stranded DNA 2783 
together randomly, which could lead to loss of sequences around the breakpoint. All types of 2784 
DNA repair are indispensable for normal cellular and organismal function. 2785 
 2786 
Figure 4. Mitochondria and oxidative stress 2787 
(A) Mitochondria represent the main source for reactive oxygen species (ROS) within eukaryotic 2788 
cells as the oxidative respiration processes take place in the inner membrane of mitochondria, 2789 
utilizing a special electron transport chain. Increased respiration rate due to metabolic changes 2790 
and reduced antioxidant accessibility may also increase generation of ROS, which can damage the 2791 
mitochondrial genome as well (indicated by thick arrow). (B) Accumulation of mutations in the 2792 
mitochondrial genome may lead to malfunction in the electron transport chain in aberrant 2793 
mitochondria, that consequently produce an elevated rate of ROS. Removal of aberrant 2794 
mitochondria is a key process for maintaining oxidative balance in cells. 2795 
 2796 
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Figure 5. Macroautophagy  2797 
This figure depicts macroautophagy which is the only mechanisms in cells able to remove 2798 
aberrant mitochondria and large protein aggregates. (A) First, formation of a double membrane 2799 
structure, the phagophore, is initiated around the target. (B) The expansion of the double 2800 
membrane structure around the target will eventually form a vesicle, called autophagosome. c. 2801 
When the autophagosome fuses with a lysosome, degradation of the autophagosome’s content can 2802 
take place and resulting molecular compounds can be recycled thereafter. 2803 
 2804 
Figure 6. Signaling pathways 2805 
This figure illustrates some of the many signaling pathways that have been connected to aging. 2806 
Activating interactions are shown with arrows, while inhibiting interactions are represented by bar 2807 
headed lines. (A) Almost all of the age-related signaling pathways converge on the metabolic 2808 
signal integrator mTORC1 complex, which includes the mTOR kinase together with RPTOR and 2809 
other proteins. mTORC1 integrates stimuli to fine tune metabolic processes, protein synthesis, 2810 
cell growth and autophagy. Downstream targets of mTORC1 include ribosomal proteins and 2811 
translation initiation factors, like RPS6KB1 and EIF4EBP1, as well as ULK1, which is an 2812 
activator of autophagy. As its name indicates, mTOR is the main target of rapamycin, which 2813 
inhibits its function. (B) The IGF1 signaling is considered to be the main modulator that links 2814 
autophagy to aging. Upregulation of this pathway leads to repression of autophagy and activation 2815 
of protein synthesis by mTOR. This pathway includes many proteins, most of which have kinase 2816 
activity. The PI3K enzymes transmit the signal from the IGF1 receptor by phosphorylating 2817 
phosphatidylinositol molecules in the membrane, which then activate PDPK1. From here, the 2818 
signal is forwarded to AKT (also known as PKB) by phosphorylation. AKT then inhibits the 2819 
function of the TSC1 and TSC2 proteins, and consequently releases RHEB from inhibition. 2820 
RHEB directly binds and activates the mTORC1 complex. (C) Another signaling pathway, which 2821 
acts parallel to IGF1, is the TGF-β signalization. It is implicated in cellular growth control and 2822 
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also in tumorigenesis, and inhibits autophagy. SMAD proteins transduce the TGF- β signal to 2823 
downstream targets. An important target of SMAD2/4 is the FOXO gene family. (D) FOXO 2824 
transcription factors have an evolutionary conserved function in aging regulation and integrate 2825 
several pathways to upregulate autophagy and inhibit mTORC1. (E) Sirtuins (SIRT1/2) act 2826 
contrary to the TGF-β pathway as they upregulate FOXO and thus, autophagy. Resveratrol and 2827 
caloric restriction exert their anti-aging effect through the activation of sirtuins. (F) The MAPK 2828 
proteins were also shown to play a role in aging by regulating FOXO. They serve as important 2829 
early responsive elements of different cellular stimuli and also plays a role in apoptotic cell death 2830 
induction in the case of UV-light damage. (G) AMPK integrates metabolite sensing information 2831 
and acts contrary to the IGF1 pathway: activation of AMPK leads to down-regulation of mTOR 2832 
and activation of autophagy. AMPK is the main target of metformin 2833 
Abbreviations: mTOR - mechanistic target of rapamycin; RPTOR - regulatory associated protein 2834 
of MTOR; RPS6KB1 - ribosomal protein S6 kinase, 70kD, polypeptide 1; EIF4EBP1 - eukaryotic 2835 
translation initiation factor 4E binding protein 1; ULK1- unc-51 like autophagy activating kinase 2836 
1; IGF1 - insulin-like growth factor 1; PIK3 - phosphatidylinositol-4,5-bisphosphate 3-kinase; 2837 
PDPK1 - 3-phosphoinositide dependent protein kinase 1; AKT – AKT serine/threonine kinase 1; 2838 
TSC1 - tuberous sclerosis 1; TSC2 - tuberous sclerosis 2; RHEB - Ras homolog, mTORC1 2839 
binding protein b; complex 1; TGF-β – transforming growth factor β; SMAD - MAD, mothers 2840 
against decapentaplegic; FOXO – forkhead box O; SIRT – sirtuin; MAPK - mitogen-activated 2841 
protein kinase; AMPK - adenosine monophosphate kinase; 2842 
 2843 
Figure 7. Mobilization of retroelements in the genome 2844 
This picture shows the basic mechanism of retrotransposon mobilization. (A) Normally, activity 2845 
of functional retroelements, like LINE-1, is repressed in somatic cells by methylation of CpG 2846 
islands in their promoter regions. (B) Demethylation of the transposon promoter may result in 2847 
transcriptional activation. The transcribed mRNA encodes the proteins necessary for 2848 
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retrotransposition, the Integrase (Int) and Reverse Transcriptase (RT), and also serves as template 2849 
for reverse transcription. The reverse transcribed transposon DNA will be integrated into the 2850 
genome by the Int protein, which first induces a double strand break. (C) The retroelement has 2851 
copied itself into a new genomic region. 2852 
 2853 
Figure 8. Model organisms of aging  2854 
The figure illustrates common aging model organisms, including small animal models and large 2855 
animal models used to study various aspects of aging. (A-C) Yeast (Saccharomyces cerevisiae) 2856 
and the invertebrates Caenorhabditis elegans and Drosophila melanogaster are ideal to 2857 
experimentally study the basic, conserved mechanisms of cellular – and organismal – aging. On 2858 
the other hand, they show less biological complexity than vertebrates in many aspects, and they 2859 
do not naturally develop neurodegeneration. (D-E) Vertebrate small animal models, like the 2860 
turqoise killifish (Nothobranchius furzeri) and rodents (Mus musculus and Rattus norvegicus) are 2861 
ideal to study the biological mechanisms that may be absent in invertebrates, and they can still be 2862 
rather easily used in experimental studies, including genetic manipulations. However, they 2863 
typically do not develop age-related neurodegeneration, and may lack many aspects of the 2864 
complex social and environmental influencers of human aging. (F-G) Dogs show similarities to 2865 
humans in their physiology and they tend to naturally develop age-related cognitive decline. 2866 
Laboratory dogs are traditional large animal models in pharmacology research. However, the 2867 
same way as other laboratory models, they do not represent the natural genetic and environmental 2868 
variability typical for human populations. Family dogs, on the other hand, live in the same 2869 
environment as humans do, and show a special population genetic stratification, with the presence 2870 
of genetically isolated, diverse populations (breeds). (H) Primates are the closest related to 2871 
humans, thus they may seem to be the most appropriate animals to study human aging. However, 2872 
primates are not suited for large-scale studies for many reasons, including ethical and financial 2873 
ones. Although they tend to develop human-like age-related neurodegeneration, they still lack the 2874 
genetic and environmental complexity (both in the laboratory and in their natural habitats), which 2875 
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may influence human aging phenotypes in human populations. (I) Human aging shows many 2876 
unique attributes, including a high prevalence of neurodegeneration. Age-related 2877 
neurodegeneration is hard to study in most animals, and translational experiments have had many 2878 
limitations so far. Brain aging may be fundamentally affected by non-genetic factors, including 2879 
diet, exercise and social environment, which seem challenging to be modelled under laboratory 2880 
conditions to reflect the natural circumstances of human populations. 2881 
 2882 
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